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Abstract
Emerging cell-based therapeutics hold promise to revolutionize the way we treat disea-
ses, and the field has gained considerable momentum in the past decade. As a conse-
quence, many cell-based therapeutics have reached clinical development. The availability
of clinical-scale downstream processing strategies for cell-based products presents a cri-
tical juncture between basic research and clinical development. Cell-based therapeutics
need to be provided in high purities, since certain contaminants can cause severe adverse
reactions. Aqueous two-phase systems (ATPS) facilitate the label-free, scalable, and cost-
effective separation of cells, and present a promising tool for downstream processing of
cell-based therapeutics. ATPS have been subject of research since the 1950s, nonetheless,
the knowledge about the mechanisms underlying cell partitioning is limited. As a result,
the development of effective downstream processes requires the optimization of many dif-
ferent parameters, and, even though the applicability of ATPS for preparative-scale cell
separation is well established, laborious empirical process optimizations have hampered
widespread application of ATPS in cell purification.
This thesis is centered around the development of preparative-scale downstream proces-
sing strategies for cell-based products. The scope of the first part of this thesis is the
development of an integrated high-throughput screening (HTS)-platform for downstream
process development for cell-based therapeutics using ATPS. The second part of this
thesis describes the application of this HTS-platform to study mechanisms in ATPS-
mediated cell separation, determine key process parameters, and conduct case studies on
downstream process design.
The first section of this thesis deals with the evaluation of analytical technologies for
high-throughput (HT)-downstream process development for cell-based products. In or-
der to design novel HTS-platforms for downstream processing of cell-based drugs, robust,
accurate, and sensitive HT-cell quantification assays are required. It is crucial that the
utilized assays are robust towards changes in buffer composition and produce reliable
results over a wide range of medium densities and viscosities. Accordingly, a comparative
study on HT-cell quantification assays was performed, where sensitivity, dynamic ran-
ge, and precision were evaluated for a number of methods that differ in their respective
mechanism. In addition, the performance of these methods was assessed over a range of
buffer compositions, medium densities, and viscosities, to evaluate assay robustness. This
benchmark study was designed as a guide for selecting HT-cell quantification assays for
a specific application. The study revealed that both CellTiter-Glo
TM
and HT-flow cyto-
metry are excellent tools for HT-cell quantification. Both methods showed broad working
ranges, high precision, and excellent robustness. Moreover, HT-flow cytometry enables
the simultaneous analysis of multiple parameters, such as cell viability, cell cycle distri-
bution, and the expression of surface markers, to identify various cell types in complex
mixtures. HT-flow cytometry is thus an ideal tool for cell quantification and analysis in
HT-downstream process development for cell-based products.
The second section of this thesis describes the development and validation of an automa-
ted robotic screening that enables HT-cell partitioning analysis in ATPS. The availabi-
lity of miniaturized and fully automated screening-platforms presents a crucial enabling
technology for downstream processing of cell-based products. The reduction in time and
material consumption enables the systematic investigation of key parameters in cell parti-
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tioning and thus facilitates more directed downstream process development. Moreover, it
will enable researchers to gain a more detailed understanding of the mechanisms underly-
ing cell partitioning in ATPS. The screening was implemented on a robotic liquid-handling
station and comprises a fully automated screening process, from ATPS preparation to cell
quantification and analysis using HT-flow cytometry. The study demonstrates that this
setup enables fast and systematic investigation of factors influencing cell partitioning.
In a first case study, separation conditions for the differentiable promyelocytic cell line
HL-60 in polyethylene glycol (PEG)-dextran ATPS were examined, and it was shown
that the separation of CD11b-positive and CD11b-negative HL-60 cells is possible after
partial DMSO-mediated differentiation towards the granulocytic lineage. The influence
of salt composition, pH, and tie-line length on the resolution of CD11b-positive and
CD11b-negative HL-60 was evaluated, and separation conditions were optimized. Using
a countercurrent distribution (CCD)-model, optimal separation conditions for a multi-
stage purification process were investigated. The modeling data indicate that complete
peak separation is possible with 30 transfers, and > 93% of CD11b-positive HL-60 cells
can be recovered with > 99% purity.
The third section of this thesis describes the application of the previously developed
screening-platform to investigate the influence of polymer molecular weight and tie-line
length on the resolution of five model cell lines in charge-sensitive PEG-dextran AT-
PS, which enable cell separation based on surface charge-associated properties. In or-
der to enable multiplexing of HT-partitioning analysis in ATPS, a barcoding strategy
using different CellTracker
TM
dyes in a combinatorial fashion was developed. This ena-
bled a substantial reduction in time and material consumption, and it was shown that
CellTracker
TM
dyes are an excellent tool for multiplexing in screenings investigating cell
surface properties, as they are retained inside living cells and do not alter cell surface
properties. The study describes how polymer molecular weight and tie-line length influ-
ence cell partitioning in charge-sensitive ATPS, and that the combination of low molecular
weight PEGs and high molecular weight dextrans enable the highest resolution of the five
cell lines. Furthermore, the study demonstrates that the separability of each cell line from
the mixture is highly dependent on the polymer molecular weight composition and tie-line
length. Finally, it was shown that cell surface charge-dependent cell partitioning due to
an interfacial Donnan potential is the major driving force in ATPS containing phosphate,
independent of polymer molecular weight and tie-line length. Using a CCD-model it was
demonstrated that the conducted screenings yielded conditions that enable the isolation
of four of the five cell lines with high purity (>99.9%) and high yield in a single CCD-run.
The final section of this thesis describes the design of a purification strategy for the
two model cell lines HL-60 and L929 based on HTS-data and CCD-modeling using PEG-
dextran ATPS. Subsequently, the CCD-model was experimentally validated, showing ex-
cellent congruence between model and experimental data. The study showed that CCD-
models are highly accurate and, in combination with HTS-data, present a powerful tool
in downstream process development. Finally, the influence of cell cycle phase on cell par-
titioning and the resolution of HL-60 and L929 was analyzed, which may interfere with
the robustness of a purification process. As cells pass through the cell cycle, a multitude
of changes takes places, such as changes in cell volume, density, DNA content, protein
expression, and consequently cell surface properties. The study revealed that while cell
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cycle phase is a significant factor in cell partitioning, cell type-specific differences in sur-
face properties were the main driving force. Constant growth conditions are, however, a
means to further increase process robustness.
In summary, the HTS-method developed in this work enables faster, cheaper, and more
directed downstream process development for cell-based products, and presents a power-
ful enabling technology for translational research. The conducted case studies identified
key parameters in cell separation and provide a benchmark for future applications. Future





Innovative Zelltherapien versprechen die Behandlung von Krankheiten zu revolutionieren
und das Feld der Zelltherapeutika hat im letzten Jahrzehnt bedeutend an Dynamik ge-
wonnen. Infolgedessen sind viele Zelltherapeutika inzwischen in der klinischen Entwick-
lung angelangt. Die Verfügbarkeit von Aufarbeitungs (engl. Downstream Processing)-
Strategien für Zelltherapeutika im klinischen Maßstab stellt eine kritische Schnittstelle
zwischen Grundlagenforschung und klinischer Entwicklung dar. Zelltherapeutika müssen
in hoher Reinheit vorliegen, da bestimmte Kontaminanten schwerwiegende Nebenwirkun-
gen hervorrufen können. Wässrige Zweiphasensysteme (engl. aqueous two-phase systems
(ATPS)) ermöglichen die Marker-freie, skalierbare und kosteneffiziente Separation von
Zellen und stellen somit eine vielversprechende Methode für die Aufarbeitung von Zellthe-
rapeutika dar und obwohl ATPS bereits seit den 1950er Jahren Gegenstand der Forschung
sind, ist das Wissen über die zugrunde liegenden Mechanismen bisher begrenzt. Daher ist
zur Entwicklung von effektiven Aufarbeitungsverfahren die Optimierung einer Vielzahl
von Parametern notwendig. Obwohl die Anwendbarkeit von ATPS zur präparativen Zell-
separation bereits vielfach aufgezeigt wurde, verhinderte die arbeitsintensive empirische
Prozessoptimierung bisher die breite Anwendung.
Das zentrale Thema dieser Dissertation ist die Entwicklung von präparativen Aufar-
beitungsverfahren für Zell-basierte Produkte. Der erste Teil dieser Arbeit beschreibt die
Entwicklung einer integrierten Hochdurchsatz-Screening (engl. high-throughput screening
(HTS))-Plattform für die Entwicklung von Aufarbeitungsverfahren für Zelltherapeuti-
ka mittels ATPS. Im zweiten Teil der Arbeit wird diese HTS-Plattform angewandt um
die der Zellseparation mittels ATPS zugrunde liegenden Mechanismen zu untersuchen,
Schlüsselparameter zu identifizieren und Fallstudien zur Entwicklung von Aufarbeitungs-
prozessen mit verschiedenen Modellsystemen durchzuführen.
Im ersten Abschnitt dieser Arbeit wurden verschiedene analytische Methoden für die
Hochdurchsatz (HT)-Aufarbeitungsprozessentwicklung für Zell-basierte Produkte evalu-
iert. Um neue HTS-Plattformen für die Aufarbeitung von zell-basierten Produkten zu ent-
wickeln, werden robuste, präzise und sensitive HT-Zellquantifizierungsmethoden benötigt.
Außerdem ist es entscheidend, dass die verwendeten Methoden robust gegenüber Verände-
rungen in der Pufferzusammensetzung sind, sowie verlässliche Ergebnisse unabhängig
von Mediendichte und Viskosität liefern. Diesbezüglich wurde eine Vergleichsstudie mit
diversen HT-Zellquantifizierungsmethoden durchgeführt, um die Sensitivität, den dyna-
mischen Bereich und die Präzision der Methoden zu ermitteln. Außerdem wurde die Lei-
stung dieser Methoden in Abhängigkeit der Pufferzusammensetzung, Mediendichte und
Viskosität untersucht, um die Robustheit der einzelnen Methoden zu validieren. Diese
Studie wurde konzipiert, um die Auswahl geeigneter HT-Zellquantifizierungsmethoden
für spezifische Anwendungen zu ermöglichen. Der Methodenvergleich ergab, dass so-
wohl CellTiter-Glo
TM
als auch HT-Durchflusszytometrie exzellente Methoden für die HT-
Zellquantifizierung sind. Beide Methoden zeigten einen breiten Arbeitsbereich sowie hohe
Präzision und Robustheit. Zudem ermöglicht die HT-Durchflusszytometrie die gleichzeiti-
ge Analyse mehrerer Parameter, wie Zellvitalität, Zellzyklusverteilung, sowie die Expres-
sion von Oberflächenmarkern zur Identifizierung verschiedener Zellarten in komplexen
Zellpopulationen. HT-Durchflusszytometrie ist somit eine ideale Methode zur Zellquan-
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tifizierung und -analyse in der HT-Aufarbeitungsprozessentwicklung von Zell-basierten
Produkten.
Der zweite Abschnitt der Arbeit beschreibt die Entwicklung und Validierung eines au-
tomatisierten robotergestützten Screeningverfahrens, das die HT-Analytik der Zellvertei-
lung in ATPS ermöglicht. Die Verwendung von miniaturisierten und vollautomatisier-
ten Screeningplattformen stellt eine wichtige Grundlagentechnologie in der Aufarbeitung
von Zell-basierten Produkten dar. Die daraus resultierende Zeit- und Kostenreduktion
ermöglicht die systematische Untersuchung von Schlüsselparametern in der Zellseparati-
on und somit eine zielgerichtete Aufarbeitungsprozessentwicklung. Zudem ermöglicht die
Verwendung von HTS-Technologien es Wissenschaftlern ein detailliertes mechanistisches
Verständnis der Zellverteilung in ATPS zu erlangen. Die Screeningmethode wurde auf
einer Pipettierroboterplattform etabliert und beinhaltet einen vollautomatisierten Scree-
ningprozess, von der ATPS-Präparation bis hin zur Zellquantifizierung und -analyse mit-
tels HT-Durchflusszytometrie. Die Studie zeigte, dass dieser Versuchsaufbau eine schnelle
und systematische Untersuchung von Schlüsselfaktoren in der Zellverteilung ermöglicht.
In einer ersten Fallstudie wurden Separationsbedingungen für die differenzierbare promye-
lozytische Zelllinie HL-60 in Polyethylenglycol (PEG)–Dextran ATPS untersucht, und es
konnte gezeigt werden, dass die Separation von CD11b-positiven und CD11b–negativen
HL-60 Zellen nach partieller DMSO-induzierter granulozytischer Differenzierung möglich
ist. Im Rahmen der Studie wurde der Einfluss von Salzzusammensetzung, pH-Wert und
Konodenlänge auf die Verteilung von CD11b-positiven und CD11b–negativen HL-60 Zel-
len evaluiert und die Separationsbedingungen optimiert. Durch die Verwendung eines
Gegenstromverteilungs (engl. countercurrent distribution (CCD)) -Modells wurden opti-
male Separationsbedingungen für einen mehrstufigen Aufreinigungsprozess validiert. Die
Modelldaten zeigen, dass eine Auftrennung in 30 Verteilungsschritten möglich ist und
dass >93% der Cd11b-positiven HL-60 Zellen mit einer Reinheit von >99% isoliert wer-
den können.
Im dritten Abschnitt dieser Arbeit wurde die zuvor entwickelte Screeningmethode einge-
setzt um den Einfluss von Polymermolekulargewicht und Konodenlänge auf die Separa-
tion von fünf Modellzelllinien in ladungsabhängigen (engl. charge-sensitive) PEG-Dextran
ATPS zu untersuchen, welche die Zellseparation basierend auf Oberflächenladungs–
assoziierten Eigenschaften ermöglichen. Um die gleichzeitige Verteilungsanalyse mehrerer
Zelllinien zu ermöglichen, wurde eine ’Barcoding’-Strategie entwickelt, welche auf dem
kombinatorischen Einsatz der CellTracker
TM
Farbstoffen beruht und eine signifikante Re-
duktion des Zeit- und Materialverbrauchs ermöglicht. Es konnte gezeigt werden, dass
CellTracker
TM
Farbstoffe hervorragend für Screenings geeignet sind, welche die Untersuchung von Zello-
berflächeneigenschaften zum Ziel haben, da die Farbstoffe im Inneren der Zelle in ein zel-
limpermeables Reaktionsprodukt umgesetzt werden und somit keine Veränderung der Zel-
loberflächeneigenschaften zur Folge haben. Diese Studie beschreibt, wie das Polymermo-
lekulargewicht und die Konodenlänge die Zellseparation in ladungsabhängigen ATPS be-
einflussen und dass die Kombination aus niedermolekularen PEGs und hochmolekularen
Dextranen die höchste Auflösung der fünf Zelllinien ermöglicht. Außerdem konnte gezeigt
werden, dass die Separierbarkeit der einzelnen Zelllinie aus der Mischung stark abhängig
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von der Zusammensetzung der Polymermolekulargewichte und der Konodenlänge ist.
Weiterhin wurde in der Studie gezeigt, dass die oberflächenladungsabhängige Zellvertei-
lung aufgrund der Ausbildung eines Donnan-Potentials ein Hauptfaktor in der Zellvertei-
lung in phosphathaltigen ATPS ist, unabhängig von Polymermolekulargewicht und Ko-
nodenlänge. Durch die Verwendung eines CCD-Modells konnten Separationsbedingungen
identifiziert werden, welche die Isolierung von vier der fünf Zelllinien mit hoher Reinheit
(>99,9%) und hoher Ausbeute in einem CCD-Lauf ermöglichen.
Im letzten Abschnitt dieser Arbeit wurde eine Aufarbeitungsstrategie für die Modell-
zelllinien HL-60 und L929 in PEG-Dextran ATPS, basierend auf HTS-Daten und CCD-
Modellen entwickelt. Die experimentelle Validierung des CCD-Modells ergab eine exzel-
lente Übereinstimmung von experimentellen und Modelldaten. Die Studie zeigte, dass
CCD-Modelle sehr akkurat sind und in Kombination mit HTS-Daten eine wichtige Me-
thode in der Entwicklung von Aufarbeitungsprozessen darstellen. Abschließend wurde der
Einfluss der Zellzyklusphase auf die Verteilung und Auflösung von HL-60 und L929 analy-
siert, da dies die Robustheit des Aufreinigungsprozesses beeinflussen kann. Im Laufe des
Zellzyklus finden eine Vielzahl an zellulären Veränderungen, wie z.B. die Änderung des
Zellvolumens, der Dichte, des DNA-Gehalts, der Proteinexpression und somit der Ober-
flächeneigenschaften statt. Die Studie ergab, dass obwohl die Zellzyklusphase ein signifi-
kanter Faktor in der Zellverteilung ist, die Zellseparation primär von Zelltyp-spezifische
Unterschieden der Oberflächeneigenschaften abhängig ist. Konstante Wachstumsbedin-
gungen sind jedoch ein geeignetes Mittel um die Prozessrobustheit zu steigern.
Zusammenfassend ermöglicht die hier entwickelte HTS-Methode eine schnellere, kosten-
günstigere und zielgerichteter Entwicklung von Aufarbeitungsverfahren für Zell-basierte
Produkte und stellt somit eine wichtige Technologie für die translationale Forschung dar.
Die durchgeführten Fallstudien identifizierten Schlüsselparameter in der Zellseparation
und stellen einen Bezugspunkt für zukünftige Anwendungen dar. Die zukünftige Nut-
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Fueled by the invention of genetic engineering technologies, the emergence of biologics
more than three decades ago has revolutionized medicine, which has long been dominated
by small-molecule drugs. Today, countless peptide- and protein-based therapeutics have
been licensed. Their huge success stems from their highly specific biological functions,
which cannot be mimicked by small molecules. As a result, biologics have improved
therapeutic effects, enable the treatment of formerly incurable diseases, and cause con-
siderably less adverse reactions. The emergence of cell-based therapeutics presents the
next turning point for pharmaceutical industry. The use of living cells as therapeutic
agents holds great promise for medicine, as cells are capable of performing complex bi-
ological functions, can sense diverse biological signals and perform a series of biological
responses (Fischbach et al., 2013; Leader et al., 2008). While most immunosuppressive
drugs, for example, massively and non-specifically suppress immune reactions, rendering
patients prone to infections, regulatory T-cells can be employed as ”smart” therapeutic
agents. Regulatory T-cells are capable of selectively controlling immune responses by
controlling the activity of various immune cells in an antigen-specific manner. Thus, they
can for example mediate highly specific immune tolerance for an organ graft, leaving the
patient’s immune response against pathogens intact (Tang and Bluestone, 2013). To-
day, cell-based therapeutics for numerous diseases and from a variety of cell sources have
made their way to clinical development (Ratcliffe et al., 2013; Trounson and McDonald,
2015). A critical juncture between research and translational science is the availability of
clinical-scale downstream processing strategies for cell-based products, since therapeutic
cells need to be provided in high purities to ensure product safety.
Aqueous two-phase systems (ATPS) present a gentle, cost-effective, label-free, and scal-
able method for cell purification, and are well established in downstream processing of
biopharmaceuticals (Albertsson, 1986; Soares et al., 2015; Walter et al., 1985). Moreover,
polyethylene-glycol (PEG)-dextran ATPS have been successfully used to separate cells
according to their surface properties with high selectivity and resolution (Albertsson,
1986; Walter et al., 1985). Using multi-step partitioning, such as countercurrent distri-
bution (CCD), even complex cell mixtures could be effectively separated (Albertsson and
Barid, 1962; Walter et al., 1985). Nonetheless, the development of efficient downstream
processes requires the optimization of many different parameters, hampering widespread
application of ATPS in cell purification. In the past decade, high-throughput screening
(HTS)-technologies have become state-of-the-art in downstream process (DSP) devel-
opment of biopharmaceuticals, such as protein- and DNA-based drugs ( Lacki, 2014).
These technologies have facilitated miniaturized, parallelized, and fully automated ex-
perimental setups, and have consequently enabled faster, cheaper, and more directed
DSP development. In combination with Design of Experiments (DoE) and modelling
tools, they present a powerful instrument to elicit mechanisms underlying separation and
design purification strategies for novel targets. The implementation of HTS-tools in DSP
development for cell-based therapeutics will likewise open up new possibilities for process





While the idea of using living cells as therapeutic agents is as old as the invention of blood
transfusion, the progress in stem cell technology and molecular biology in the past decade
has opened up an entirely new perspective on cell-based therapeutics. Today, cell-based
therapeutics for a variety of diseases and from a variety of cell sources have made their
way into clinical trials (Ratcliffe et al., 2013; Trounson and McDonald, 2015). Presently,
approximately 1900 clinical trials on cell-based therapeutics are ongoing worldwide, and
the cell therapy market is estimated to reach annual commercial sales of $20 billion by
2025 (Buckler et al., 2016; Ratcliffe et al., 2013).
The field of cell-based therapeutics, while still in it’s infancy, is vast and extremely di-
verse. The most common form of cell-based therapy is cell replacement therapy, where
lost cell types, e.g. hematopoietic stem cells or pancreatic beta-cells, are replaced. A
special form of cell replacement therapy is tissue engineering, where tissues, and eventu-
ally entire organs, are rebuild. Successful examples are skin, bone, and cartilage grafts,
which have been approved almost a decade ago (Dodson and Levine, 2015). In addition,
there are cell-based immunotherapies, where various cell types of the immune system
are used to trigger, modulate, or suppress specific immune reactions. Cancer vaccines,
for example, employ specifically engineered immune cells, such as dendritic cells (DC),
natural killer (NK) cells, or cytotoxic T-cells, to target cancer cells and eradicate them
by triggering a specific immune response. Finally, there are numerous approaches for
cell-based drug delivery, where cells are specifically engineered to deliver biologics. Stud-
ies show that the cell-based delivery of therapeutic proteins enables the administration
of steady protein concentrations over prolonged timespans, with improved therapeutic
effects and considerably simpler treatment plans for the patients (Dove, 2003; Fliervoet
and Mastrobattista, 2016; Pierigè et al., 2008; Ye and Mahato, 2008).
Cell-based therapies can be further classified into allogenic and autologous therapies. Au-
tologous cell-based therapies use the patient’s own cells as the therapeutic agent, while
allogenic cell-based therapies use cells from a donor. While the allograft approach enables
large-scale production of cell-based drugs, specific strategies are required to circumvent
graft rejection. Autologous cell-based therapies, on the other hand, do not require im-
mune protection as they are custom made for each patient from their own cells, which in
turn creates a variety of economic, regulatory, and logistic obstacles (Dove, 2003). More-
over, cell-based therapeutics can be simple transplants or transfusions, or cells which have
been specifically engineered for a therapeutic application, so called Advanced Therapy
Medicinal Products (ATMPs) (Mount et al., 2015).
The emergence of stem cell technologies and the invention of induced pluripotent stem
cells (iPSC) about a decade ago, has provided a novel source for numerous cell-based
therapeutics (Daley and Scadden, 2008; Fischbach et al., 2013; Takahashi and Yamanaka,
2006). Embryonic stem cells (ESC) possess the unique ability of unlimited self-renewal
and the ability to differentiate into to all cell types of the body (pluripotency). The
ability to generate pluripotent stem cells (PSC) by directed reprogramming of somatic
cells towards induced pluripotent stem cells (iPSC) has alleviated the ethical concerns
associated with ESC, and thus represents one of the most crucial enabling technologies
for modern regenerative medicine. iPSC thus provide a unique and potentially unlimited
source for both autologous and allogenic cell-based therapeutics. A particularly promis-
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1.1 Cell-based therapeutics
ing approach is the use of iPSC-banks for HLA haplotype-matched allografts (Daley and
Scadden, 2008; Turner et al., 2013). In the past decade numerous differentiation protocols
for PSC have been established, paving the way countless novel cell-based therapeutics.
As a consequence, clinical trials for various stem cell-based therapeutics are presently
conducted (Trounson and McDonald, 2015). In Table 1 examples of cell-based thera-
peutics that have been approved by the authorities or are currently undergoing clinical
trials are summarized (Dodson and Levine, 2015; Fliervoet and Mastrobattista, 2016;
Mount et al., 2015; Ratcliffe et al., 2013; Trounson and McDonald, 2015).
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Table 1: Overview and current status of cell-based therapeutics for various indications and from different
cell sources that have been approved by the authorities or are currently undergoing clinical trials (Dodson
and Levine, 2015; Fliervoet and Mastrobattista, 2016; Mount et al., 2015; Ratcliffe et al., 2013; Trounson
and McDonald, 2015). PBMC: peripheral blood mononuclear cells; ALL: acute lymphoblastic leukemia;
ALS: amyotrophic lateral sclerosis; ASC: adult stem cells; CAR: chimeric antigen receptor; CNS: central
nervous system; GvHD: graft-vs-host disease; hESC: human embryonic stem cells; MSC: mesenchymal
stem cells; NSC: neural stem cells.
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1.2 Downstream processing of cell-based therapeutics
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1.1.1 Manufacturing of cell-based therapeutics
As an industry, cell-based therapies are still in their infancy, and manufacturing protocols
are still in early stages of development (Heathman et al., 2015). Nonetheless, scalable
manufacturing processes need to be developed in parallel with clinical assessment, and
the final manufacturing process needs to be in place before the products enter phase
III clinical trials (Heathman et al., 2015). Thus, it is essential that scalable and eco-
nomically viable up- and downstream processing strategies are available as cell-based
therapeutic enter clinical development. Manufacturing protocols for cell-based therapeu-
tics are as diverse as the cell sources they are derived from. While hematopoietic stem
cells from HLA-matched donors require small-scale isolation and purification protocols,
iPSC-derived allografts require complex expansion, differentiation, harvesting, purifica-
tion, and encapsulation protocols (Darkins and Mandenius, 2013; Sart et al., 2014).
Pancreatic progenitors for the treatment of type I diabetes, for example, are manufac-
tured by a complex expansion and differentiation protocol (Schulz, 2015; Schulz et al.,
2012). In the first stage of the process hESC are expanded using a suspension-based
feeder-free culture method. Subsequently, a step-wise differentiation protocol towards
pancreatic endoderm is used by mimicking embryonic development. Finally, the cells are
encapsulated for transplantation to ensure immune protection of the allograft (Schulz,
2015). Moreover, the scale varies significantly, depending on the number of patients
to be treated, which can range from single-dose manufacturing processes for autologous
cell-based therapies to large-scale bioprocesses for allografts.
1.2 Downstream processing of cell-based therapeutics
Downstream processing strategies for cell-based products are a critical juncture between
basic research and translational science. The requirements on DSP are highly depen-
dent on cell source and application. Following an initial enrichment step, several specific
positive- and negative-selection steps may be required to further enrich the target cell
type and deplete critical contaminants (Al-Rubeai and Naciri, 2014; Amos et al., 2012;
Rodrigues et al., 2015; Stemberger et al., 2012). When, for example, employing hESC
or hiPSC-derived cell-based therapeutics, the propensity of tumor formation by residual
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undifferentiated or partially differentiated cells presents a key regulatory issue (Rodrigues
et al., 2015; Schriebl et al., 2010; Weil and Veraitch, 2014). Moreover, the differentiation
of PSC usually results in a mix of different cell types and differentiation stages, which
are often not fully characterized. The large size and complexity of mammalian cells,
along with the inherent heterogeneity of differentiated cell populations, presents a major
challenge for both DSP development and regulatory processes (Rodrigues et al., 2015;
Willoughby, 2009). Thus, novel cell-based therapeutics need to be assessed carefully in
order to evaluate potential risks and to design suitable purification strategies. Overall
process requirements are high purities and yields. Moreover, maintaining cell viabil-
ity, functionality, therapeutic potential, and ensuring overall safety are key requirements
(Heathman et al., 2015; Rodrigues et al., 2015; Willoughby, 2009). During the transla-
tion of the first phase of cell-based therapeutics a key manufacturing issue was to keep
manufacturing costs at a level that allows for commercial success (Dodson and Levine,
2015; Heathman et al., 2015).
1.3 Cell separation methods
At present there are a variety of cell separation methods available that differ in their spe-
cific mechanism, throughput, and selectivity (Tomlinson et al., 2013; Zhu and Murthy,
2013). They can be categorized into physical and immunoaffinity-based cell separation
methods (Figure 1). While physical cell separation technologies exploit differences in
physical properties such as density, size, surface charge or hydrophobicity, immunoaffinity-
based cell separation methods use specific-antibodies to isolate the target cell population.
For certain applications, e.g. the purification of hESC-derived cardiomyocytes, the spe-
cific metabolic properties of the target cells can be used for highly selective and cost-
effective cell purification (Tohyama et al., 2013).
1.3.1 Immunoaffinity-based cell separation methods
The antibody-mediated capture of cells based on the expression of specific surface antigens
is highly selective, and the specificity and diversity of monoclonal antibodies makes them
a powerful tool in cell purification. Thus, it is not surprising that these methods are
the most widely applied (Amos et al., 2012; Weil and Veraitch, 2014). In addition to
fluorescence activated cell sorting (FACS), immunoaffinity-based cell separation methods
are available in many different formats, including magnetic, surface, column, and bead-
based devices (Weil and Veraitch, 2014).
Magnetic activated cell sorting (MACS), a trademark name of Miltenyi Biotech for a
magnetic bead-based immunoaffinity-purification system, for example, is applied in many
clinical settings, such as the isolation of CD34+ hematopoietic stem cells (HSC) from
mobilized peripheral blood apheresis products, and regulatory T-cells (Tregs) and NK-
cells from peripheral blood mononuclear cells (PBMC) (Bluestone et al., 2015; Dahlberg
et al., 2015; Hoffmann et al., 2006; Spohn et al., 2015; Tang and Bluestone, 2013).
While immunoaffinity-based cell separation methods are usually highly selective, scalable,
and gentle with regards to cell viability, they have several drawbacks. Firstly, the use
of large amounts of clinical-grade antibodies renders the method one of the most cost-
intensive. Secondly, if several consecutive separation steps are required, purity and yield
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can be significantly reduced. Even in single-marker MACS protocols, purities and yields
vary considerably between batches, e.g. 30-90% purity, for the isolation of CD34+ HSC
from mobilized peripheral blood apheresis products (Weil and Veraitch, 2014). Moreover,
scalability and obtainable purities and yields are highly dependent on the format of the
method (Al-Rubeai and Naciri, 2014; González-González et al., 2012). While FACS e.g.
provides higher purities than other immunoaffinity-based cell separation techniques, the
scalability is highly limited (Amos et al., 2012; González-González et al., 2012; Tomlinson
et al., 2013). Thirdly, the use of positive-selection strategies poses considerable regulatory
obstacles for the treatment of patients, as antibody-labels may cause adverse cellular
reactions (Amos et al., 2012; Chen et al., 2014; Fernandes et al., 2014; Rodrigues et al.,
2015; Tomlinson et al., 2013). Finally, there are a significant number of therapeutically
relevant cell types that lack a specific surface antigen (Weil and Veraitch, 2014).
1.3.2 Physical cell separation methods
Physical cell separation technologies exploit differences in physical properties, such as
density, size, surface charge, and hydrophobicity for cell separation.
Centrifugation techniques, such as density gradient centrifugation, exploit differences in
cell density and size for cell separation. Density gradients and apheresis, for example, are
applied in many clinical settings, such as the isolation of mononuclear cells from periph-
eral blood or bone marrow (Diogo et al., 2012; Tomlinson et al., 2013). Other methods
include membrane filtration, dielectrophoresis (DEP), field flow fractionation (FFF), and
ATPS, as summarized in Figure 1 (Al-Rubeai and Naciri, 2014; González-González et
al., 2012; Tomlinson et al., 2013; Zhu and Murthy, 2013). While membrane filtration
separates cells based on their size (Al-Rubeai and Naciri, 2014), dielectrophoretic cell
separation is based on the application of an electrical field, enabling cell separation based
on electro-physical properties, as well as cell size and density (González-González et al.,
2012; Zhu and Murthy, 2013). In FFF, a laminar flow mobile phase is used to separate
cells. In gravitational FFF, e.g., cells position within the laminar flow according to their
mass, density, and size, and can thus be separated. In addition, FFF can be combined
with DEP or centrifugation to enhance resolution (González-González et al., 2012; Zhu
and Murthy, 2013). The partitioning of cells in ATPS is based on their surface properties,
i.e. charge and hydrophobicity, and has successfully been combined with immunoaffinity-
purification (González-González et al., 2012; Sousa et al., 2011).
Physical cell separation methods have significantly lower selectivity than immunoaffinity-
based cell purification methods, but have been successfully applied as initial enrichment
steps (Rodrigues et al., 2015). In addition, they can be used in an orthogonal and/or
multi-stage fashion for increased selectivity. All of these methods have the great advan-
tage of being label-free, cost-effective and scalable, even though there are differences in
scalability. While membrane filtration, ATPS, and centrifugation techniques are highly
scalable, the scalability of DEP and FFF are more limited and these methods are mostly
applied in microfluidic applications (González-González et al., 2012; Tomlinson et al.,
2013; Zhu and Murthy, 2013). To date, most of these methods are still in early stages
of development and have only been applied in laboratory settings (Tomlinson et al.,
2013). Nonetheless, many of these methods hold great promise for future industrial-scale





































































Figure 1: Overview of immunoaffinity-based and physical cell separation techniques. ATPS: aqueous
two-phase systems; DEP: dielectrophoresis; FACS: fluorescence activated cell-sorting; FFF: field-flow
fractionation; m: mass; mAb: monoclonal antibody; MACS: magnetic activated cell sorting; ρ: density.
1.4 Aqueous two-phase systems (ATPS)
ATPS have been successfully used in downstream processing of biomolecules, such as pro-
teins, nucleic acids, viruses, cells, and cell organelles, for more than 50 years (Albertsson,
1986; Walter et al., 1985). ATPS-research was pioneered by Per-Åke Albertsson in 1956,
who discovered phase formation when PEG was mixed with highly concentrated phos-
phate buffers (Walter et al., 1985). His work initiated intensive research on two-phase
extraction of biological materials for analytical and preparative purposes, and ATPS-
technology is now making its way towards industrial bioprocessing (Soares et al., 2015).
ATPS can be formed by a variety of components, usually polymers and salts, which are
















Figure 2: Schematic phase diagram of a PEG-dextran aqueous two-phase system (ATPS). The binodal
curve marks the polymer concentrations above which phase separation occurs. The tie-lines connect
systems with equal phase composition but varying volume ratios, and the nodes between binodal and tie-
lines depict the compositions of top and bottom phase, respectively (Hatti-Kaul, 2000). C: concentration.
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The phases are enriched in either of the components and exhibit different physicochemical
properties. By now, a large number of compound pairs have been identified that are
capable of phase formation. A schematic phase diagram for a PEG-dextran ATPS is
depicted in Figure 2. The binodal curve marks the critical polymer concentrations
for phase formation and the tie-lines connect systems with equal phase composition but
varying volume ratios. The nodes between binodal and tie-lines depict the respective
compositions of top and bottom phase (Hatti-Kaul, 2000; Walter et al., 1985). For cell
separation, polymer-polymer ATPS, more specifically PEG-dextran ATPS, are the most
widely applied. PEG-dextran ATPS can be buffered and made isotonic by the addition
of salts.
1.4.1 Cell partitioning in aqueous-two phase systems (ATPS)
The partitioning of molecules and particles in ATPS is, in addition to specific interactions
with the phase-forming components, driven by Brownian motion and interfacial forces.
While the Brownian motion distributes molecules or particles randomly within the ATPS,
the interfacial tension acts to minimize the interfacial area. The adsorption of cells and
other particles to the interface reduces the interfacial area, and consequently the total
free energy of the system. As a result, cells and other particles above a certain diameter
have a strong tendency to adsorb to the interface, in dependence of the interfacial tension.
Thus, partitioning into either phase can only take place if the interaction with the cell
surface is strong enough to ”pull” the cells out of the interface. The higher the interfacial
tension, the stronger the required interaction to enable partitioning (Albertsson, 1986;
Forciniti et al., 1990; Walter et al., 1985). Depending on specific interactions, cells and
other particles partition between either of the bulk phases, i.e. top and bottom phase,
and the interface (Albertsson and Barid, 1962; Baird et al., 1961).
The partitioning coefficient P of a cell type can thus be defined as the ratio of cells
in either of the bulk phases (equation 1).
P =
CTP × V TP
CCtr × V Ctr
(1)
C: cell concentration; V: volume; TP: top phase; Ctr: control
While the mechanisms underlying cell partitioning in ATPS are not entirely understood,
two main factors in cell separation have been identified: surface charge and membrane
lipid composition. Salts with polyvalent anions, e.g. phosphate, have a higher affinity for
the dextran-rich bottom phase, while salts of halides, for example NaCl, partition almost
equally between the phases. Unequal partitioning of a salt results in the generation of
an interfacial electrostatic potential difference (Donnan potential), and molecules and
particles partition in such ATPS according to their surface charge (Gascoine and Fisher,
1984; Reitherman et al., 1973; Vis et al., 2014; Walter et al., 1985). In PEG-dextran
ATPS with moderate interfacial tensions containing phosphate, cells can therefore be
separated based on their surface charge (charge-dependent partitioning). As cells have
a negative net surface charge, they partition into the top phase in ATPS containing
phosphate (Cabral, 2007; Reitherman et al., 1973). Charge-independent cell separation,
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on the other hand, is possible in ATPS containing e.g. sodium chloride (charge-insensitive
ATPS). More precisely, partitioning coefficients of distinct cell types in charge-insensitive
ATPS have been correlated with their membrane lipid composition (Albertsson, 1986;
Gascoine and Fisher, 1984; Walter, 1978; Walter et al., 1985).
Both interfacial tension and Donnan potential are dependent on polymer type, polymer
molecular weight, tie-line length (TLL), temperature, salt type and concentration, and
the presence of certain additives (Fan et al., 1998; Forciniti et al., 1990; King et al., 1988;
Luther and Glatz, 1995; Walter et al., 1985).
Cell partitioning and the resolution of distinct cell populations is thus highly dependent
on all of these parameters. However, the interaction of these parameters in respect to
cell partitioning and the resolution of different cell populations remains unclear. By
varying this multitude of factors, separation conditions can be optimized for a specific
application. Since the partitioning of cells in ATPS is fully reversible, independent of
their concentration and the presence of other cells types, CCD can be used for multi-
stage separation processes (Albertsson and Barid, 1962; Baird et al., 1961).
1.4.2 Multi-stage countercurrent distribution (CCD)
While a single purification step can yield good results in some cases, differences in parti-
tioning coefficients do generally not suffice to obtain high purities in a single extraction
step. In order to increase resolution between target cells and contaminants, multi-stage
separation processes such as CCD can be applied. CCD was developed by Craig (Craig
and Post, 1949) and is nowadays a well-established method in liquid-liquid extraction. In
CCD the top phase is transferred stepwise while the bottom phase is retained (Figure 3).
Between transfers, the ATPS are mixed and allowed to separate by gravity. Depending
on the application, the interface can either be transferred or retained (Johansson, 1998).
As cells partition between either of the bulk phases and the interface, the interface is
retained when cells partition between top phase and interface, and transferred when the
cells partition between interface and bottom phase. Cells that partition largely into the
top phase e.g. move faster through the CCD-device than cells that partition largely to
the interface, and the two cell populations can thus be separated. Even though numerous
devices for liquid-liquid chromatography have been introduced, i.e. hydrodynamic coun-
tercurrent chromatography (CCC) and hydrostatic centrifugal partition chromatography
(CPC), CCD has so far proven the most suitable for cell separation (Albertsson and
Barid, 1962; Walter et al., 1985). Due to low pressures and shear forces, high cell viabili-
ties can be obtained. In addition, settling by gravity enables cell separation according to
surface properties, rather than densities, as it may be the case for centrifugation-based
methods, depending on the mode of operation and centrifugation force.
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Figure 3: Scheme of the countercurrent distribution (CCD)-principle for aqueous two-phase systems
(ATPS) in which cells partition between top phase and the interface. The top phase is transferred
stepwise. Between the transfers ATPS are mixed and phases are separated by gravity (Johansson, 1998).
1.4.3 Modeling countercurrent distribution (CCD)
Based on partitioning ratios determined in batch experiments, CCD-curves can be mod-




r(1 − P )n-r (2)
where F represents the fraction of the total cell population appearing in each theoretical
cavity r of the CCD-apparatus, n represents the total number of transfers, and P repre-
sents the fraction of cells in either of the bulk phases. The fraction of cells in each cavity
will be given by a binomial distribution (Walter et al., 1985). Based on given P -values,
a purification process can be designed. Highly accurate models can be obtained if all
relevant parameters, i.e. vessel geometry, volume, mixing intensity, mixing time, temper-
ature, and phase separation time, are identical between batch and CCD-experiments. By
increasing the number of transfers, the resolution can be increased as shown in Figure
4. However, processing time increases accordingly, which can reduce cell viability. By
decreasing the temperature to 4◦C, or the use of certain additives, prolonged processing
times can be realized (Albertsson, 1986; Walter et al., 1985). This, however, needs to be
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Figure 4: Predicted countercurrent distribution (CCD)-curves for different partitioning ratios (P) with
30 (left) and 120 (right) transfers (Walter et al., 1985).
1.5 High-throughput process development (HTPD)
HTS-technology has been state-of-the-art in drug development for more than two decades,
and automation, miniaturization, and parallelization of numerous methods has resulted
in a significant increase in throughput and a concomitant reduction in time and material
consumption. Likewise, HTS-platforms are used in various other scientific disciplines such
as fundamental research, diagnostics, and biotechnology (An and Tolliday, 2010; Bensch
et al., 2005; Hertzberg and Pope, 2000; Macarron et al., 2011). In the past decade,
HTS-technologies have gained considerable importance in DSP development of biophar-
maceuticals such as protein- and DNA-based drugs, and are, by now, available for most
platform technologies e.g. column chromatography, crystallization, and ATPS (Bensch et
al., 2005, 2007; Coffman et al., 2008; Oelmeier et al., 2012; Wiendahl et al., 2008; Zang et
al., 2011). In combination with DoE, modeling, and simulation data, HTS-technologies
present a powerful tool for the directed design of purification strategies (Coffman et al.,
2008; Oelmeier et al., 2012). The knowledge gained in DSP development for complex
biomolecules, such as therapeutic antibodies, is now expected to drive the development
of industrial-scale downstream processing of cell-based pharmaceuticals (Ratcliffe et al.,
2013).
1.5.1 HT-cell quantification methods
In order to design novel HTS-platforms for downstream processing of cell-based drugs,
robust, accurate, and sensitive HT-cell quantification assays are required. Currently, a
vast number of direct and indirect cell quantification methods are available (Figure 5).
Direct cell quantification assays detect the cells themselves, while indirect cell quantifi-
cation methods quantify intracellular targets. Direct cell quantification assays include
light microscopy in combination with trypan blue staining (e.g. hemocytometer, Cedex
(Roche)), impedance-based cell counting (e.g. Coulter Counter), and light scattering as
performed in flow cytometry. The majority of cell quantification methods, though, are
based on indirect means of cell enumeration, i.e. the quantification of genomic DNA (e.g.
CyQuant R©(LifeTechnologies
TM
)), total protein (e.g. Bradford Assay), specific enzymes
(e.g. CellTracker
TM
, LiveDead Cell Viability Assay), or certain metabolites, for instance
ATP (e.g. CellTiter-Glo
TM
(Promega), ATPlite (Perkin Elmer)).
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Figure 5: Overview of state-of-the-art direct and indirect cell quantification methods.
While some assays enable the exclusive quantification of live cells, other assays enable
the discrimination between live and dead cells. Quantification of dead cells is usually
performed by investigating membrane permeability using a dye that is impermeable to
live, but not dead cells. Most assay types are further available with different readouts,






The availability of clinical-scale downstream processing strategies for cell-based prod-
ucts presents a critical juncture between basic research and clinical development. Due
to the large size and inherent complexity of mammalian cells, the design of effective
downstream processing strategies remains challenging. The requirements on downstream
processes (DSP) are highly dependent on cell source and application. Following an initial
enrichment step, several specific positive and negative selections steps may be required
to further enrich the target cell type and deplete critical contaminants. Aqueous two-
phase systems (ATPS) facilitate the label-free, scalable, and cost-effective separation of
cells, and present a promising tool for downstream processing of cell-based therapeutics.
They are especially promising as an initial enrichment step, since they are highly scalable
and cost-effective. Nonetheless, the development of effective downstream processes re-
quires the optimization of many different parameters, hampering widespread application
of ATPS in cell purification. In the past decade, HTS-technologies have become state-
of-the-art in DSP development of biopharmaceuticals such as protein- and DNA-based
drugs. These technologies have facilitated miniaturized, parallelized, and fully automated
experimental setups, and have consequently enabled faster, cheaper, and more directed
DSP development. In combination with Design of Experiments (DoE) and modelling
tools, they present a powerful instrument to elicit mechanisms underlying separation and
design purification strategies for novel targets. The implementation of HTS-tools in DSP
development for cell-based therapeutics will likewise open up new possibilities for process
design, and thus presents a crucial enabling technology for the translation of cell-based
therapeutics.
The present work focusses on the implementation of an integrated HTS-platform for DSP
development for cell-based products using ATPS. In this context robust, accurate, and
sensitive high-throughput (HT)-cell quantification assays are required. It is crucial that
the utilized assays are robust towards changes in buffer composition and produce reliable
results over a wide range of medium densities and viscosities.
The scope of the first part of this thesis is thus the implementation of analytical tech-
nologies for HT-DSP development for cell-based products. In this context a comparative
study will be conducted that assesses state-of-the-art cell quantification methods regard-
ing their applicability in HT-DSP development.
The focus of the second part of this thesis is the application of this HTS-platform to
study mechanisms in ATPS-mediated cell separation, determine key process parameters,
and conduct case studies on the design of a DSP. The vast number of process parameters
in aqueous two-phase extraction presents a major bottleneck for effective DSP devel-
opment. The utilization of a HTS-approach will enable the systematic investigation of
numerous parameters, will help to identify their role in cell separation, and enable the
determination of key parameters for efficient and directed DSP development. Likewise,
a HTS-approach will enable us to assess the influence of numerous cellular parameters,
e.g. cell cycle phase, on cell partitioning, and consequently their influence on process
robustness.
The combination of DoE, HTS-data, and multi-stage process models will further enable
the design of complex DSP based on batch-data with minimal time and material con-
sumption. The knowledge gained from these screenings can further be used to develop a
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more detailed mechanistic understanding of cell partitioning in ATPS, which will even-
tually enable the implementation of more model-based DSP development approaches.
The overall objective of this thesis is the investigation of ATPS as a downstream pro-
cessing tool for cell-based therapeutics. The use of a HTS-platform in combination with
multi-stage models will enable the identification of key parameters in cell separation,
resulting in more directed DSP development, and will finally help to provide a more
detailed mechanistic understanding of cell partitioning in ATPS.
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1. High-throughput cell quantification assays for use in cell purification de-
velopment – Enabling technologies for cell production
S. Zimmermann, S. Gretzinger, C. Scheeder, M.-L. Schwab, S.A. Oelmeier, A. Os-
berghaus, E. Gottwald, J. Hubbuch
Biotechnol. J. (2016), doi: 10.1002/biot.201500577
This article presents a comparative study on high-throughput (HT)-cell quantifi-
cation assays for downstream process (DSP) development for cell-based products.
Several cell quantification methods that differ in their respective mechanism were
validated for their applicability in high-throughput screening (HTS)-platforms for
DSP development. The compared methods differed significantly in sensitivity, dy-
namic range, robustness, and throughput, and the study provides a guideline for
selecting the most suitable assay for a specific application.
2. High-throughput downstream process development for cell-based prod-
ucts using aqueous two-phase systems
S. Zimmermann, S. Gretzinger, M.-L. Schwab, C. Scheeder, P.K. Zimmermann,
S.A. Oelmeier, E. Gottwald, A. Bogsnes, M. Hansson, A. Staby, J. Hubbuch
J. Chrom. A. (2016), doi: 10.1016/j.chroma.2016.08.025
This article describes the development and validation of an automated robotic
screening that enables HT-cell partitioning analysis in aqueous two-phase systems
(ATPS). In a first case study, separation conditions for the differentiable promye-
locytic cell line HL-60 in PEG-dextran ATPS were examined, and it was shown
that the separation of CD11b-positive and CD11b-negative HL-60 cells is possible
after partial DMSO-mediated differentiation towards the granulocytic lineage. The
influence of salt composition, pH, and tie-line length (TLL) on the resolution of the
two cell populations was evaluated, and separation conditions were optimized using
a countercurrent distribution (CCD)-model.
3. Cell separation in aqueous two-phase systems – Influence of polymer
molecular weight and tie-line length on the resolution of five model cell
lines
S. Zimmermann‡, S. Gretzinger‡, P.K. Zimmermann, A. Bogsnes, M. Hansson, J.
Hubbuch (‡: contributed equally)
J. Chrom A, submitted manuscript
This study explores the influence of polymer molecular weight and TLL on the res-
olution of five model cell lines in charge-sensitive PEG-dextran ATPS using a HTS-
approach in combination with CCD-modelling. In addition, a barcoding-strategy
was developed that enables multiplexing in cell partitioning analysis. The study
demonstrates that the separability of each cell line from the mixture is highly depen-
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dent on the polymer molecular weight composition and TLL. Finally, it was shown
that cell surface charge-dependent cell partitioning due to an interfacial Donnan
potential is the major driving force in ATPS containing phosphate, independent of
polymer molecular weight and tie-line length.
4. High-throughput downstream process development for cell-based prod-
ucts using aqueous two-phase systems (ATPS) – A case study
S. Zimmermann, C. Scheeder, P.K. Zimmermann, A. Bogsnes, M. Hansson, A.
Staby, J. Hubbuch
Biotechnol. J., submitted manuscript
In this case study a purification strategy for two model cell lines based on HTS-data
and CCD-modeling was designed and validated experimentally. The study showed
excellent congruence between CCD-model and experimental data, indicating that
CCD-models in combination with HTS-data are a powerful tool in downstream
process development. Finally, the influence of cell cycle phase on cell partitioning
and the resolution of the two model cell lines was analyzed, which may interfere
with the robustness of a purification process. The study revealed that while cell
cycle phase is a significant factor in cell partitioning, cell type-specific differences
in surface properties were the main driving force.
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Abstract
High-throughput screening (HTS) technology is gaining increasing importance in down-
stream process development of cell-based products. The development of such HTS-
technologies, however, is highly dependent on the availability of robust, accurate, and
sensitive high-throughput cell quantification methods. In this article, we compare state-
of-the-art cell quantification methods with focus on their applicability in HTS-platforms
for downstream processing of cell-based products. Sensitivity, dynamic range, and preci-
sion were evaluated for four methods that differ in their respective mechanism. In addi-
tion, we evaluated the performance of these methods over a range of buffer compositions,
medium densities, and viscosities, representing conditions found in many downstream
processing methods. We found that CellTiter-GloTM and flow cytometry are excellent
tools for high-throughput cell quantification. Both methods have broad working ranges
(3-4 log) and performed well over a wide range of buffer compositions. In comparison,
CyQuant R©Direct and CellTrackerTM had smaller working ranges and were more sensitive
to changes in buffer composition. For fast and sensitive quantification of a single cell
type, CellTiter-GloTM performed best, while for more complex cell mixtures flow cytom-
etry is the method of choice. Our analysis will facilitate the selection of the most suitable
method for a specific application and provides a benchmark for future HTS development
in downstream processing of cell-based products.
Keywords: cell-based products, cell quantification assays, downstream processing, high-
throughput screening (HTS)
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1 Introduction
High-Throughput screening (HTS) technology has been state-of-the art in drug devel-
opment for more than two decades, and, by now, most pharmaceutical companies use
HTS in lead discovery. As a result, many of the recently approved small-molecule drugs
and biopharmaceuticals have been identified by HTS [1,2]. Likewise, high-throughput
screening platforms are used in various other scientific disciplines such as basic research,
diagnostics, and biotechnology [1–4]. In the past decade, HTS-technology has also gained
increasing importance in downstream process development of biopharmaceuticals, such as
protein- and DNA-based drugs [4]. High-throughput platforms are currently available for
most platform technologies, including column chromatography, crystallization, and aque-
ous two-phase systems (ATPS) [4–10]. These technologies have facilitated faster, cheaper,
and more directed downstream process development. In combination with modeling and
simulation data, they present a powerful tool for the directed design of purification strate-
gies for novel targets.
As the development of cell-based pharmaceuticals is advancing, new scalable downstream
processing strategies are required. The knowledge gained in downstream process develop-
ment for complex biomolecules, such as therapeutic antibodies, is now expected to drive
the development of downstream processing of cell-based pharmaceuticals [11]. This is
supported by the fact that both chromatography as well as ATPS have been successfully
used for cell separation [12–19]. In order to design novel HTS platforms for downstream
processing of cell-based drugs, robust, accurate, and sensitive high-throughput cell quan-
tification assays are required. For application of cell quantification assays in HTS plat-
forms for cell separation, it is crucial that the utilized assays are robust towards changes
in buffer composition, but should also give reliable results over a wide range of medium
densities and viscosities.
Presently, a vast number of direct and indirect cell quantification methods are avail-
able [20]. Direct cell quantification assays detect the cells themselves, while indirect cell
quantification methods quantify intracellular targets, such as genomic DNA, proteins or
metabolites. Direct cell quantification assays include light microscopy in combination
with trypan blue staining (e.g. hemocytometer, Cedex (Roche)), impedance based cell
counting (e.g. Coulter Counter), and light scattering, as performed in flow cytometry.
The majority of cell quantification methods, however, are based on indirect means of cell
enumeration. Indirect cell quantification assays are based on quantification of genomic
DNA (e.g. CyQuant R©(LifeTechnologiesTM)), total protein (e.g. Bradford Assay), specific
enzymes (e.g. CellTrackerTM, LiveDead Cell Viability Assay), or certain metabolites,
for instance adenosine triphosphate (ATP), e.g. CellTiter-GloTM (Promega), ATPlite
(Perkin Elmer).
Some of these assays exclusively quantify live cells, while others are able to discriminate
between live and dead cells. Identification of dead cells is performed by investigating
membrane permeability using a dye that is impermeable to live, but not to dead cells. In
addition, one can choose between different readouts for many of the assays formats, e.g.
absorbance, fluorescence or luminescence. Likewise, this has a significant effect on the
sensitivity and robustness of the assay. With such an abundance of assay types, it can
be difficult to find the appropriate assay for the respective application, and it has been
shown that each assay type has its limitations, depending on their mechanism of action
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[20,21]. Therefore, it is important to understand the underlying principles and carefully
validate different assays for a new application. To our knowledge, a comparative analy-
sis of different cell quantification assays for high-throughput applications in downstream
processing of cell-based products had not been conducted to date.
In this article, we compared four high-throughput cell quantification methods that dif-
fer in their respective mechanism. The following indirect high-throughput cell quan-
tification methods were chosen: CellTiter-GloTM, a luciferase reagent that quantifies
intracellular ATP, CyQuant R©Direct, a cell-permeant fluorescent nucleic acid stain, and
the CellTrackerTM dyes, which belong to the group of thiol-reactive esterase substrates.
Moreover, we chose flow cytometry as a direct cell quantification method. We evaluated
sensitivity, dynamic range, and precision for each of these four methods. In addition, we
evaluated their performance over a range of buffer compositions, medium densities, repre-
senting conditions found in many downstream processing methods. Finally, we compared
the four methods regarding assay time and material costs.
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2 Materials & Methods
2.1 Disposables
For fluorescence measurements, 96-well UV-Star plates (Greiner Bio-One, Kremsmünster,
Austria) and for luminescence measurements, LIA flat-bottom 96-well plates (Greiner
Bio-One) were used. For flow cytometry, 96-well U-bottom plates (BD Falcon San Jose,
CA, USA) were used. For all other purposes, polypropylene flat-bottom microplates
(Greiner Bio-One) and 1.3 mL deep well plates (Nalgene Nunc, Rochester, NY, USA)
were used.
2.2 Software
Excel 2013 (Microsoft, Redmond, WA, USA) was used as import format and for data
storage, as well as for data evaluation and visualization. The Tecan Inifinite R©Pro M200
plate reader was controlled using iControl 1.9 (Tecan, Crailsheim, Germany). For sta-
tistical data analysis, Matlab R2014a (The MathWorks, Inc., Natick, ME, USA) was
used. BD FACSDiva 8.0 was used to control the BD LSR Fortessa Cell Analyzer and for
analysis of flow cytometry data (BD Biosciences, San Jose, CA, USA).
2.3 Preparation of buffers and stock solutions
Stock solutions of 5% Dextran 500,000 (Pharmacosmos A/S, Holbaek, Denmark, cat.
551005009007, Batch No.: HT3229) and 5% PEG 8,000 (Sigma Aldrich, St. Louis,
MO, USA, cat. P2139, Batch No.: 059Ko121) were prepared in Dulbecco´s Phosphate
Buffered Saline (DPBS) (Life TechnologiesTM, Carlsbad, CA, USA). All other buffers
and stock solutions were prepared with ultra-pure water (0.55 µS/cm) obtained from an
Arium R©proUV water system (Satorius, Göttingen, Germany). 500 mM phosphate buffer
stock solutions were prepared by using di- (Merck Millipore, Darmstadt, Germany) and
monobasic sodium phosphate (Sigma Aldrich) in varying ratios, in order to obtain specific
pH-values (241 mM Na2HPO4, and 259.4 mM NaH2PO4 for pH 6.6, 353 mM Na2HPO4,
and 147.4 mM NaH2PO4 for pH 7.0, 430 mM NaH2PO4, and 70.6 mM NaH2PO4 for
pH 7.4). Sodium chloride (Merck Millipore) was prepared as a 500 mM stock solution.
A 500.8 mM citrate buffer stock solution, pH 6.6 was prepared using 495 mM sodium
citrate (Sigma Aldrich) and 5.8 mM acetic acid (Merck Millipore). A 500 mM Tris-
buffer, pH 7.0 was prepared using 473 mM Tris-HCl (AppliChem, Darmstadt, Germany)
and 26.8 mM sodium hydroxide (Merck Millipore). 1 x Hank´s Balanced Salt Solution
(HBSS), pH 7.0, was prepared using 5.33 mM potassium chloride (VWR, Darmstadt,
Germany), 0.49 mM magnesium chloride (Sigma Aldrich), 1.26 mM calcium chloride,
0.41 mM magnesium sulfate, 0.44 mM potassium phosphate, monobasic, 4.17 mM sodium
bicarbonate, 137.93 mM sodium chloride, 0.34 mM sodium phosphate, dibasic, and 5.56
mM D-glucose (Merck Millipore). Working solutions were prepared at 129 mM sodium
phosphate pH 6.6, 118 mM sodium phosphate pH 7.0, 111 mM sodium phosphate pH 7.4,
150 mM sodium chloride, 150 mM Tris-buffer, and 100 mM citrate buffer, respectively, to
obtain physiological osmolarities. Osmolarities were verified using a VAPRO R© 5600 vapor
pressure osmometer (Wescor Inc., Logan, UT, USA), and all buffers had osmolarities
within the physiological range (290-310 mOs). All buffers and polymer solutions were
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filtrated (Ø 0.22 µm PES, VWR). Buffers were stored at room temperature and polymer
solutions were stored at 4 ◦C.
2.4 Cell culture
The promyeloic cell line HL-60 was purchased from CLS (Cell lines Service, Eppelheim,
Germany) and propagated at 37 ◦C in a humidified 5% CO2 incubator. Cell culture
media and supplements were purchased from Life TechnologiesTM. Cells were grown in
RPMI 1640 with GlutaMAX-1, supplemented with 15% fetal bovine serum (FBS), 1%
sodium pyruvate, 1% non-essential amino acids (NEAA), and 0.5% Penicillin/ Strepto-
mycin. Cells were split to a concentration of 2 x 105 cells per mL every 3-4 days. For
assay calibration, HL-60 cells were counted using a Neubauer improved hemocytometer
(Marienfeld, Land-Königshofen, Germany).
2.5 Cell quantification assays
2.5.1 Cell quantification using CellTrackerTM dyes
CellTrackerTM Orange CMRA (9’-(4 [and 5]-chloromethyl-2-carboxyphenyl)-7’-chloro-6’-
oxo-1,2,2,4-tetramethyl-1,2-dihydropyrido [2’,3’-6]xanthene), (Life TechnologiesTM) was
prepared as recommended by the manufacturer, and staining was performed with 10
µM CellTrackerTM Orange CMRA at 37 ◦C for 30 minutes. Subsequently, fluorescence
intensity was measured using a Tecan Inifinite R©Pro M200 plate reader (Ex.: 548 nm,
Em.: 576 nm).
2.5.2 Cell quantification using CyQuant R©Direct Cell Proliferation Assay
Cell quantification with CyQuant R©Direct Cell Proliferation Assay (Life TechnologiesTM)
was performed according to the manufacturer’s instructions, and DNA-bound dye molecules
were quantified by fluorescence measurement using a Tecan Inifinite R©Pro M200 plate
reader (Ex: 480 nm, Em.: 535 nm).
2.5.3 Cell quantification using CellTiter-GloTM Luminescent Cell Viability
Assay
CellTiter-GloTM Luminescent Cell Viability Assay Kit (Promega, Madison, WI, USA) was
used according to the manufacturer’s instructions. Luminescence intensity was measured
with a 500 ms integration time using a Tecan Inifinite R©Pro M200 plate reader.
2.5.4 Cell quantification using flow cytometry
Flow cytometry was performed using a LSR Fortessa from BD Bioscience equipped with
a BDTM High Throughput Sampler (HTS). The high throughput sampler was operated at
the following settings: sample flow rate: 3 µL/s, sample volume: 100 µL, mixing volume:
100 µL, mixing speed: 200 µL/s, and four mixing cycles. For cell quantification, cells were
diluted with 2x FACS staining buffer (DPBS with 1% (w/v) bovine serum albumin (BSA)
(Miltenyi Biotec, Bergisch Gladbach, Germany) and 4 mM EDTA (Life TechnologiesTM)).
Discrimination between live and dead cells was performed using forward (FSC) and side
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(SSC) scatter signal. Dead cells were gated using a control sample with heat-inactivated
cells (70 ◦C, 10 minutes).
2.6 Validation of assay performance
The respective cell quantification assays were validated in regards to sensitivity, linear
range, precision, and robustness, according to the recommendations of the ICH guidelines
[22].
2.6.1 Linearity and calibration
For calibration, a dilution series of 107 to 102 cells per mL, with a total of 12 to 19 cali-
bration points including a blank control, was prepared and quantified with the respective
method. All measurements were performed in technical triplicates. As cell quantification
was assessed over several orders of magnitude, homoscedasticity was not given in most
cases, as confirmed by the application of an F-Test. Thus, weighted least squares linear
regression (WLSLR) was performed as described by Almeida et al. [23]. The following
weighting factors (wi) were compared: 1/x
0.5, 1/x, 1/x2, 1/y0.5, 1/y, 1/y2. Relative errors
(%RE) were calculated using equation (1), and residuals were visualized in order to assess













Cnom, nominal standard concentration
2.6.2 Limit of detection and quantitation










S, slope of calibration function
SD, standard deviation of the response
2.6.3 Range
The linear range was defined as the range of concentrations above the detection limit,
where a linear correlation between cell number and readout was observed (R2 > 0.995).
The working range was defined as the section of the linear range where the variation
coefficient (CV ) was below 10%.
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2.6.4 Robustness
Robustness was evaluated by quantifying 105 cells per mL in the presence of different
salts and polymers. PEG 8000 and Dextran 500 000 were used at final concentrations
between 0.5 and 2%. Buffers containing different salts and pH-values were used at physi-
ological osmolarities, undiluted, as well as 10-fold diluted with DPBS. The recovery rate
was calculated as the percentage of cells detected compared to the DPBS controls. To de-
termine if the recovery was altered significantly, pairwise Student’s t-test was performed,
provided that equal variances could be asserted by using an F-test. A difference in means
was considered significant for p-values < 0.01.
3 PUBLICATIONS & MANUSCRIPTS
40
3 Results
In the present work, we compare four cell quantification methods regarding their ap-
plicability in high throughput downstream process development for cell-based products.
Thus, we evaluated the assays with regards to their performance over a range of buffer
compositions, medium densities, and viscosities.
3.1 High-throughput flow cytometry, CellTiter-GloTM, CyQuant
R© Direct, and the CellTrackerTM dyes are suitable assays for
high-throughput cell quantification in downstream process-
ing applications
A pre-selection of assays was performed taking the following criteria into account: Firstly,
the measured parameters should correlate linearly with cell number to facilitate the use
of an internal standard with two or three data points. Thereby, the influence of batch
to batch variations can be eliminated, which ensures that data are comparable over a
large set of experiments [24]. Secondly, it is essential that the assay has a broad working
range, high sensitivity, and short processing times. Furthermore, the assay handling and
readout need to be compatible with automated liquid handling.
Direct Indirect







































Figure 1: Overview of state–of–the–art cell quantification methods.
Thirdly, it is crucial that the utilized assay is not only robust towards changes in buffer
composition, but should also give reliable results over a wide range of medium densi-
ties and viscosities. Moreover, working with different medium densities makes the use
of centrifugation steps challenging, since cells cannot easily be sedimented at medium
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densities similar to the cell’s density. Therefore, an add-mix-and-measure type of assay
is favorable. This, likewise, is of great advantage regarding simplicity of handling and
reproducibility. Based on these criteria, we chose the following indirect cell quantification
methods: CellTiter-GloTM, CyQuant R©Direct, and the CellTrackerTM dyes. Moreover, we
chose flow cytometry as a direct cell quantification method, since it is suitable for high
throughput applications and allows the discrimination between numerous cell populations
based on the staining of specific intracellular and extracellular markers. Since cellular
DNA content is highly regulated, nucleic acid stains are known to be a reliable tool for cell
quantification [20,25]. From the many nucleic acid stains available, CyQuant R©Direct was
chosen, since this assay was developed for high throughput applications and is therefore
designed as a simple add-mix-and-measure assay. Moreover, it has been shown to be more
sensitive than many other nucleic acid stains [25–27]. Another advantage of this assay is
that it contains a dye quenching reagent that is excluded from living cells, thus, only live
cells are quantified. However, it is important to consider the influence of cell cycle on cell
proliferation assays based on DNA quantification. If there is a change in the distribution
between the different cell cycle phases, there will be an over- or underestimation of cell
numbers [25,28].
Another commonly used type of fluorescent dyes for determining the number of viable
cells are esterase substrates (e.g. Calcein AM, Cell TrackerTM dyes) [29]. Cell TrackerTM
dyes are live cell stains that are retained within living cells and belong to the group of
thiol-reactive esterase substrates. These dyes were chosen, since they offer a versatile
and simple means of cell tracking and quantification. CellTrackerTM Green CMFDA and
CellTrackerTM orange CMRA are non-fluorescent unless retained inside the cells where
they become transformed into a cell impermeant fluorescent product [30]. This allows
cell quantification without washing steps in a simple add-mix-and-measure format, since
excess dye molecules are non-fluorescent, and, therefore, do not interfere with the read-
out. In addition, these dyes can be easily combined with live cell impermeant nucleic
acid stains (e.g. Sytox stains, Ethidium homodimer-1) for dead cell quantification.
The most widely applied cell quantification assays are based on the quantification of
metabolic activity and assays like MTT, MTS, and Alamar BlueTM, and are commonly
used in toxicity studies [20,28]. From this assay category we chose the CellTiter-GloTM
Luminescent Cell Viability Assay, which determines intracellular ATP levels by a lu-
ciferin/ luciferase reaction. The assay exclusively quantifies living cells, as ATP is rapidly
degraded upon cell death. This assay is, like the others, a simple and fast add-mix-and-
measure type of assay. A potential drawback of this assay is a bias due to changes in
metabolic activity, which needs to be evaluated for each application [20,28]. Flow cy-
tometric enumeration of cells is a standard analytical technique in clinical diagnostics
[31,32]. This, however, is only possible, if the flow cytometer is equipped with precision
pumps or if counting beads are used. Using counting beads, however, gives additional
uncertainty, since the pipetting of accurate bead number is challenging [31]. Thus, we
evaluated if accurate cell counting is nonetheless possible using a high throughput sam-
pler which can analyze defined sample volumes (Figure 1 & Table 1).

























































































































































































































































































































































































































































































































































































































































































































































































Figure 2: Working ranges of CellTrackerTM, CyQuant R©Direct, CellTiter-GloTM, and flow cytometry.
A dilution series of 107 to 102 cells per mL, including a blank control, was prepared and quantified with
the respective method (n =3 technical replicates), followed by determination of working ranges.
3.2 Sensitivity and working range differ significantly between
assay-types
For high-throughput cell quantification in downstream processing of cells, it is essential
that the assay has a broad working range and high sensitivity. Therefore, we evaluated
sensitivity and working range by preparing a dilution series between 107 and 102 cells
per mL and subsequent quantification using the respective assay. From these data, the
detection limit and working range were determined. Moreover, calibration was performed
using linear least-square regression analysis. If variances between the highest and lowest
concentration of the working range were not equal, weighted least squares regression anal-
ysis was performed. Regression parameters as well as working ranges of the respective
methods are summarized in Table 1 & Table 2. As shown in Figure 2, the working
ranges of the evaluated assays differed significantly.









CellTrackerTM >0.05 none 1.67 0.9996 4.7 0.0165 (0.0155–0.0175) 34600 (34300–34800)
CyQuant Direct R© <0.01 1/x2 0.01 0.9989 4.5 0.3518 (0.3302–0.3735) 8393 (8348–8439)
CellTiter-GloTM <0.01 1/x 0.01 0.9998 4.3 1.772 (1.745–1.799) 372.7 (232.6–512.7)
Flow cytometry <0.01 1/x -0.02 0.9993 2.9 0.1079 (0.1058–0.11) 58.72 (25.97–91.58)
a) Values for 95% prediction bounds are shown in parentheses
CellTrackerTM and CyQuant R©Direct showed working ranges of 1.5 and 2 orders of magni-
tude, and limits of detection of 104 and 103 cells per mL, respectively (Figure 3, A+B,
& Table 2). However, it should be noted that the regression curve for CellTrackerTM
showed a comparably small slope, thus, the assay is less sensitive to small changes in cell
number. CellTiter-GloTM and flow cytometry showed larger working ranges with 3 and 4
orders of magnitude, respectively. The detection limits were comparable with <102 and
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Figure 3: Regression analysis of HL-60 cells quantified with CellTrackerTM (A), CyQuant R©Direct (B),
CellTiter-GloTM (C), and flow cytometry (D). A dilution series of 107 to 102 cells per mL, including
a blank control, was prepared and quantified with the respective method (n=3 technical replicates).
Calibration curves were calculated using weighted least squares linear regression and 95% confidence
intervals and coefficients of determination were calculated. Curve fit (color) and 95% confidence intervals
(grey, dotted) are depicted in each plot. RFU: relative fluorescence units, RLU: relative luminescence
units.
5 x 102 cells per mL (Figure 3, C+D & Table 2). All assays showed high linearity (R2
> 0.998) and %RE were below 0.02%, except for CellTrackerTM which was significantly
higher with 1.67%.
3.3 Assay precision is primarily dependent on liquid handling
precision
Precision was evaluated by comparing coefficients of variation over the working range of
the four assays (Table 2). Mean variation coefficients ranged from 4.3 to 4.7%, and
were comparable for all indirect cell quantification assays. For flow cytometry the mean
variation coefficient was slightly lower with 2.9%. This, however, is most likely due to the
smaller number of pipetting steps. Our data indicate that precision of the four assays is
mostly dependent on liquid handling precision, which can be much higher for automated
liquid-handling.
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3.4 Flow cytometry shows higher robustness than plate-based
assays
Assay robustness is an important factor in high-throughput screening development. Par-
ticularly in downstream processing of cell-based products, robustness towards changes in
buffer compositions, pH, and the presence of different polymers is a prerequisite. Fluo-
rescence and luminescence detection, as well as enzymatic reactions, can be influenced by
changes is pH, ionic composition, and light scattering. It is, however, unclear to what ex-
tent such changes influence the performance of the assays. Moreover, changes in viscosity
can influence liquid handling as well as mixing and diffusion kinetics. We thus evaluated
the robustness of each assay by quantifying 105 cells per mL in the presence of different
salts and polymers that are commonly used in chromatography and aqueous two-phase
systems. All buffers were used undiluted and 10-fold diluted with DPBS. The recovery
rate was calculated as the percentage of cells detected compared to the DPBS controls.
All three indirect cell quantification assays were to some degree sensitive to changes in
buffer composition and pH, while flow cytometry was insensitive to all tested buffers and
polymers. Buffer effects were the most distinct for CyQuant R©Direct and the CellTrackerTM
dyes. Here, all tested buffers reduced the number of detected cells by 30 to 50%. The
CellTiter-GloTM assay, on the other hand, was sensitive to the presence of phosphate
buffers of varying pH as well as sodium citrate, but not to other buffers, such as HBSS
and Tris-HCl. Buffer effects were, however, not observed when the buffers were 10-fold
diluted with DPBS (Figure 4, E−G). Moreover, we observed a significant effect (p<
0.01) of both PEG 8,000 and dextran 500,000 on cell quantification with CyQuant R©Direct
and CellTrackerTM at concentrations above 1% (w/w), where the number of detected cells
was reduced by up to 17%. Both, CellTiter-GloTM and flow cytometry were, however, not
significantly influenced by up to 2% (w/w) of PEG 8,000 and dextran 500,000 (Figure
4, A−C). It should be noted though that higher polymer concentrations will result in
inaccurate results (data not shown).
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Figure 4: Influence of different polymers (A–D) and salts (E–H) on quantification of HL–60 cells.
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Figure 4: (continued) Influence of different polymers (A–D) and salts (E–H) on quantification of HL–
60 cells. A+E: CellTrackerTM; B+F: CyQuant R©Direct; C+G: CellTiter-GloTM; D+H: flow cytometry.
Robustness was evaluated by quantifying 105 cells per mL in the presence of different salts and polymers.
Buffers containing different salts and pH–values were used at physiological osmolarities, undiluted, as
well as 10–fold diluted with DPBS. Error bars indicate standard deviation of n =3 technical replicates.
Asterisks indicate significant changes in detected cell numbers (p< 0.01) as determined by Student’s
t–test.
4 Discussion
We compared four distinct high-throughput cell quantification methods that differ in
their respective mechanisms (Figure 1).
We found significant differences between the working ranges (Figure 2) and robustness
(Figure 4) of the evaluated methods. Both CellTiter-GloTM and flow cytometry are
excellent tools for high throughput cell quantification. Both methods have broad work-
ing ranges (3 and 4 log) (Table 1, Figure 2), and performed well over a wide range
of buffer compositions, medium densities, and viscosities (Figure 4). Even though the
utilized BDTM LSR Fortessa is not equipped with precision pumps, we found that when
using a high throughput sampler, accurate cell quantification is possible without the use
of counting beads. In comparison, CyQuant R©Direct and the CellTrackerTM dyes had
smaller working ranges and were more sensitive to changes in buffer composition (Ta-
ble 1). As expected, CellTiter-GloTM was the most sensitive cell quantification assay,
since luminescence-based assays are very sensitive due to the strong signal amplification.
Interestingly, flow cytometry showed comparable sensitivity. CyQuant R©Direct, however,
showed significantly lower sensitivity, with a detection limit about one order of magnitude
higher than CellTiter-GloTM and flow cytometry, while the CellTrackerTM dyes showed
the lowest sensitivity, with a detection limit about two orders of magnitude higher than
CellTiter-GloTM. Even though all assays except CellTiter-GloTM do not include a signal
amplification step, flow cytometry is more sensitive than the two fluorescence-based as-
says (Figure 2).
With the exception of flow cytometry, all assays were susceptible to changes in buffer
composition. This is due to the fact that both enzymatic reactions as well as fluores-
cence and luminescence detection are sensitive to changes in pH and ionic composition.
These influences, however, could be eliminated by 10–fold dilution with DPBS (Figure
4). In addition, the fluorescence-based assays CyQuant R©Direct and CellTrackerTM were
sensitive towards the presence of polymers, which is most likely due to increased light
scattering [33]. This was not observed when using CellTiter-GloTM, which can tolerate
moderate polymer concentrations.
Even though, flow cytometry is based on light scattering and fluorescence measurement,
cells can be quantified reliably in the presence of different salts and polymers. This is
most likely due to mode of operation, as cells are hydrodynamically focused in a fluid
stream, thereby being further diluted, and pass the lasers individually, which in turn
gives much higher sensitivity.
Using high-throughput flow cytometry for cell quantification has the advantage that other
parameters such as the expression of surface antigens can be analyzed simultaneously, if
robust, no-wash staining protocols are available. Thus, even complex cell mixtures can
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be analyzed in a single experiment, while the other cell quantification methods require
additional experiments to quantify different subpopulations of complex cell mixtures.
The evaluated methods also vary in assay time and cost of material. In 96–well format the
required processing time for CellTiter-GloTM, the CellTrackerTM dyes and CyQuant R©Direct
differ only in the incubation time of the respective reagents. Here, CellTiter-GloTM is
substantially faster than the other methods (Table 1). Using an interlaced experiential
design, the impact on total processing time can however be minimized, and since lumi-
nescence and fluorescence measurement of a 96–well plate takes less than two minutes,
sample preparation is most likely the limiting factor. Using a Tecan Freedom Evo liquid
handling station, pipetting one compound in different volumes into 96–wells takes 5–10
minutes, depending on the viscosity of the liquid. Equal volumes can be pipetted using
a 96–channel arm, which takes less than a minute. In high–throughput flow cytometry
the processing time is highly dependent on the flow cytometer settings (i.e. sample vol-
ume and flow rate). The settings described here are optimized for high sensitivity, thus,
the processing time for a 96–well plate is comparably long. In high–throughput mode,
a 96–well plate can be analyzed in less than 15 minutes, however, due to the decreased
sample volume, the sensitivity decreases and the working range shifts towards higher
cell numbers (data not shown). In 384–well format the differences in processing time
increase, while fluorescence and luminescence measurement take 4–8 minutes, depend-
ing on the integration time, flow cytometric analysis of a 384–well plate takes almost
an hour in high–throughput mode. However, there are strategies to increase throughput
dramatically using cell barcoding which is not an option for plate–based assays [34]. As
for the plate–based assays, the influence of sample preparation on total processing time
can be minimized using an interlaced experimental design. While flow cytometry has sig-
nificantly higher instrumentation costs, the cost of material are comparably low (Table
1). The choice of an assay or a combination of assays is, thus, highly dependent on the
application and the dynamic range, robustness, and throughput needed.
In summary, we showed that both CellTiter-GloTM and flow cytometry are excellent tools
for high–throughput cell quantification in downstream process development for cell–based
products. Both methods have broad working ranges and perform well over a wide range
of buffer compositions, medium densities, and viscosities. In addition, both assays can
be performed in 96– and 384–well format. For fast and sensitive quantification of a single
cell type, CellTiter-GloTM is the method of choice, while for more complex cell mixtures
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Abstract
As the clinical development of cell-based therapeutics has evolved immensely within the
past years, downstream processing strategies become more relevant than ever. Aqueous
two–phase systems (ATPS) enable the label–free, scalable, and cost–effective separation of
cells, making them a promising tool for downstream processing of cell–based therapeutics.
Here, we report the development of an automated robotic screening that enables high–
throughput cell partitioning analysis in ATPS. We demonstrate that this setup enables
fast and systematic investigation of factors influencing cell partitioning. Moreover, we ex-
amined and optimized separation conditions for the differentiable promyelocytic cell line
HL–60 and used a countercurrent distribution–model to investigate optimal separation
conditions for a multi–stage purification process. Finally, we show that the separation
of CD11b–positive and CD11b–negative HL–60 cells is possible after partial DMSO–
mediated differentiation towards the granulocytic lineage. The modeling data indicate
that complete peak separation is possible with 30 transfers, and > 93% of CD11b–positive
HL–60 cells can be recovered with > 99% purity. The here described screening platform
facilitates faster, cheaper, and more directed downstream process development for cell–
based therapeutics and presents a powerful tool for translational research.
Keywords: high–throughput screening (HTS); downstream processing of cell–based
products; label–free cell separation; aqueous two–phase systems (ATPS); high–throughput
flow cytometry
3 PUBLICATIONS & MANUSCRIPTS
54
1 Introduction
High–throughput screening (HTS) technologies are state–of–the art in various scien-
tific disciplines, such as basic research, diagnostics, and biotechnology [1–4]. In the
past decade, HTS–technologies have gained increasing importance in downstream pro-
cess development of biopharmaceuticals, such as protein– and DNA–based drugs, and
are currently available for most platform technologies, including column chromatogra-
phy, crystallization, and aqueous two–phase systems (ATPS) [4–11]. These technologies
have facilitated faster, cheaper, and more directed downstream process development. In
combination with modeling and simulation data, they present a powerful tool to elicit
mechanisms underlying separation and design purification strategies for novel targets.
As cell–based therapeutics are entering the market, new scalable downstream processing
strategies are required. For clinical applications, cell–based products need to be provided
in high purities, since certain contaminants can cause severe adverse effects, such as ter-
atoma formation or graft–versus–host–disease (GvHD) [12–17]. The most widely applied
cell separation methods use cell surface antigens for affinity–purification. These meth-
ods, however, require large amounts of clinical–grade antibodies, resulting in extremely
high costs. Antibody–labels that remain on the cell surface, pose considerable regulatory
obstacles for the treatment of patients, as they can cause adverse reactions [15,16,18,19].
ATPS offer a gentle, cost–effective, label–free, and scalable means of cell purification,
and are well established in downstream processing of biopharmaceuticals [20–22]. ATPS
are aqueous solutions consisting of different phase forming compounds, e.g. polymers,
which form two immiscible phases above a certain threshold. The two phases have dis-
tinct physicochemical properties, and biomolecules partition between them according to
their physicochemical properties. It is well established that polyethylene–glycol (PEG)–
dextran ATPS can be used to separate cells according to their surface properties. It has
been shown that ATPS can be used to separate different cell types with high selectivity
and resolution. Using multi–step partitioning, such as countercurrent distribution (CCD),
even complex cell mixtures can be separated [21,23]. Nonetheless, the development of
effective downstream processes requires the optimization of many different parameters,
hampering widespread application of ATPS in cell purification.
In this work, an automated HTS–platform for the investigation of cell partitioning in
ATPS was developed and validated. The screening was implemented on a robotic liquid-
handling station (LHS), and includes all steps from ATPS preparation to cell quantifica-
tion and analysis using HT–flow cytometry. In a first case study, the partitioning of the
differentiable cell line HL–60 was evaluated in a number of ATPS. HL–60 was chosen since
it can be partially differentiated towards neutrophil granulocytes by DMSO–treatment,
and monitored using an anti–CD11b–antibody [24]. The influence of salt composition,
pH, and tie–line length (TLL) on the resolution of CD11b–positive and CD11b–negative
HL–60 was evaluated, and separation conditions were optimized. Using a CCD–model, we
investigated optimal separation conditions for a multi–stage purification process. Over-
all, we show that the here described HTS–platform enables fast and directed downstream
process development for cell–based products and will permit the systematic investigation
of mechanisms underlying cell separation in ATPS.
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2 Materials & Methods
2.1 Disposables
For absorbance measurements, UV–Star plates (Greiner Bio–One, Kremsmuenster, Aus-
tria) were used. For flow cytometry, 96–well U bottom plates (BD FalconTM , Franklin
Lakes, NJ, USA) were used. ATPS were prepared in 1.3 mL deep well plates (Nalgene
Nunc, Rochester, NY). For all other purposes, polypropylene flat–bottom microplates
(Greiner Bio–One) were used.
2.2 Software and data processing
The Tecan Freedom Evo 200 was controlled using Evoware 2.5 SP2 standard (Tecan,
Crailsheim, Germany), and the Tecan Inifinite R© Pro M200 plate reader was controlled
via Magellan 7.1 SP 1 (Tecan). For advanced applications such as sampling and cell resus-
pension, visual basic scripts were generated and fed into Evoware. Excel 2013 (Microsoft,
Redmond, WA, USA) was used as import format and for data storage. Data evaluation
and visualization was performed with Excel 2013 and Matlab R2014a (The MathWorks,
Natick, ME, USA). For statistical data analysis Matlab R2014a was used. BD FACSDiva
8.0 (BD Biosciences, San Jose, CA, USA) was used to control the BD LSR Fortessa Cell
Analyzer and for raw data analysis. For visualization of flow cytometry data, Flow Jo
V10 (Tree Star, Ashland, OR, USA) was used.
2.3 Preparation of buffers and stock solutions
All buffers and stock solutions were prepared with ultra–pure water (0.55 µS/cm) ob-
tained from an Arium R© proUV water system (Sartorius Stedim Biotech, Goettingen,
Germany). Stock solutions of 2% and 20% dextran 500,000 (Pharmacosmos A/S, Hol-
bæck, Denmark, cat. 5510 0500 9007, Batch No.: HT3229) and 30% PEG 8,000 (Sigma
Aldrich, St. Louis, MO, USA, cat. P2139, Batch No.: 059Ko121) were prepared and
dissolved on a magnetic stirrer overnight. 500 mM sodium phosphate (NaPi) buffer
stock solutions were prepared by using di– (Merck Millipore, Billerica, MA, USA) and
monobasic sodium phosphate (Sigma Aldrich) in varying ratios, in order to obtain specific
pH-values (241 mM Na2HPO4 and 259.4 mM NaH2PO4 for pH 6.6, 353 mM Na2HPO4
and 147.4 mM NaH2PO4 for pH 7.0, 430 mM Na2HPO4 and 70.6 mM NaH2PO4 for pH
7.4). 1 M NaPi buffers were prepared analogously. NaCl (Merck Millipore) was prepared
as 1 M and 500 mM stock solutions. A 1 mM methyl violet 2B stock solution (Sigma
Aldrich) was prepared in ultra–pure water. All buffers and polymer solutions were fil-
trated (Ø 0.22 µm). Buffers were stored at room temperature and polymer solutions were
stored at 4◦C. Osmolarities of the distinct ATPS were verified using a VAPRO R© 5600
vapor pressure osmometer (Wescor, Logan, UT, USA), and all ATPS had osmolarities
within the physiological range (290–310 mOs). FC–staining buffer consisted of phosphate
buffered saline (PBS) supplemented with 2 mM EDTA (Life TechnologiesTM , Carlsbad,
CA, USA) and 0.5% bovine serum albumin (BSA) (Miltenyi Biotech, Bergisch Gladbach,
Germany).
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2.4 Cell culture
All cell culture reagents were purchased from Life TechnologiesTM . The promyelocytic
cell line HL–60 and the murine fibroblast cell line L929 were purchased from CLS (Cell
lines Service, Eppelheim, Germany) and propagated at 37◦C in a humidified 5% CO2 in-
cubator. HL–60 cells were grown in RPMI 1640 with GlutaMAX supplemented with 15%
fetal bovine serum (FBS), 1% sodium pyruvate, 1% non–essential amino acids (NEAA),
and 0.5% Penicillin/ Streptomycin. L929 cells were grown in DMEM with GlutaMAX
supplemented with 10% FBS and 1% Penicillin/ Streptomycin.
2.5 Granulocytic differentiation of HL–60 cells
Granulocytic differentiation of HL–60 was induced by the addition of DMSO [24]. For
each differentiation experiment, cells were seeded at a density of 2.5 x 105 cells/mL in
culture medium supplemented with 1.25% (v/v) DMSO (Sigma Aldrich) and cultured for
7 days. During this time, cell growth was monitored and medium was changed after 3
days.
2.6 Cell TrackerTM, antibody and viability staining
In spiking experiments and to discriminate between the two cell lines, HL–60 cells were
stained with CellTrackerTM Orange CMRA (Life TechnologiesTM). 1 x 106 cells per mL
were resuspended in RPMI with GlutaMAX and stained with 0.5 µM dye at 37◦C for 30
min. The cells were subsequently resuspended in culture medium, and incubated at 37◦C
for 30 min to inactivate unbound dye molecules.
For detection of differentiated HL–60 cells, a FITC–conjugated rat–anti–human–CD11b
antibody (Miltenyi Biotech) [24] was used at a dilution of 1:100. For staining, up to 1 x
106 cells per mL were resuspended in 100 µL of FC–staining buffer, and incubated at 4◦C
in the dark for 10 min. For analysis of cell viability, cells were stained with LIVE/DEAD
Green Fixable Dead Cell Stain (Life TechnologiesTM) according to the manufacturer’s
instructions.
2.7 Cell quantification using high–throughput flow cytometry
Cells were quantified using flow cytometry as previously described [25], by analyzing a
defined sample volume. Thereby, the number of counted events can be correlated with the
cell concentration by least squares linear regression. Flow cytometry was performed using
a LSR Fortessa from BD Bioscience equipped with a BDTM High Throughput Sampler
(HTS). The high throughput sampler was operated at the following settings: sample flow
rate: 3 µL/s, sample volume: 100 µL, mixing volume: 100 µL, mixing speed: 200 µL/s,
and four mixing cycles.
2.8 Liquid–handling calibration
Liquid–handling calibration was performed for all stock solutions as described previously
[6]. For each stock solution 12 different volumes were pipetted onto the analytical balance
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in octuplicates. Pipetting parameters were optimized until an r2 of > 0.999 was reached,
residuals were evenly distributed and deviated less than 3.5% from the nominal volume.
Variation coefficients were below 1.6% for aqueous solutions and below 2% for the viscous
polymer solutions (Table A1).
2.9 HT–binodal and tie–line determination
Manual and HTS–based binodal determination was performed using a cloud point ap-
proach that has previously been established in our group [6,26]. ATPS were prepared with
increasing PEG and dextran concentrations in 0.25% (w/w) steps in 1.3 mL deep well
plates. After an initial mixing step (1,300 rpm, 8 min) using the integrated orbital shaker,
phase separation was determined by visual inspection. The curve was fitted as described
before [27,28] using least square regression. Tie–lines were determined by measuring the
phase volumes of a set of ATPS with increasing distance from the binodal. Tie–lines
were then calculated using the lever arm rule as described before [26]. Tie–line length
(TLL) and tie–line slope (STL) were determined based on concentration differences of
the phase–forming polymers in top and bottom phase as described before [20,21].
2.10 Automated high–throughput screening of cell partitioning
in aqueous two–phase systems
The automated high–throughput method was modified from Oelmeier et al. [6]. The
entire high–throughput screening was performed on a Tecan Freedom Evo R© 200 liquid–
handling station (LHS), and sample plates were transferred to the HT–sampler of the BD
LSR Fortessa for cell quantification and analysis. The LHS is equipped with an 8–port
liquid–handling arm (LiHa), a standard robotic plate handling arm (RoMa) equipped with
a centric gripper, an integrated centrifuge (Rotana 46RSC, Hettich), a rotational shaker
(Te–shakeTM , Tecan), a 96–channel liquid–handling arm (MultiChannelArmTM (MCA 96),
Tecan) with an eccentric gripper, and an integrated spectrophotometer (Infinite R© M200
Pro, Tecan).
ATPS were prepared in a 1.3 mL 96–well plate with a total volume of 637 µL. After a first
mixing step (1,300 rpm, 8 min), the plate was centrifuged (4,000 rpm, 20 min) to achieve
phase separation. An intermediate mixing step was performed (1,300 rpm, 5 min), to
reduce shear stress on the cells, before the cells were resuspended (3 cycles, aspiration
volume: 50% of total volume, pipetting speed: 182 µL/s, aspiration position: well bottom,
dispense position: liquid surface) and added to the ATPS (5 x 105 cells per well in 13
µL PBS). Subsequently, a final mixing step was performed (1,300 rpm, 2 min) and phase
separation was achieved by settling (30 min, RT). A set of internal standards containing a
defined cell number were included in each experiment. After phase separation, samples of
both phases were taken and diluted 5–fold in staining buffer. Sampling was performed as
described by [6], with the following exception: a delay of 5 s and a retraction speed of 10
mm/s were used during bottom phase sampling. The optimized pipetting parameters are
summarized in Table A2. Prior to all cell handling steps, a partitioning volume of 100
µL PBS was aspirated followed by an air gap, to protect the cells from contaminations
with system liquid (deionized water).
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2.11 Statistical data analysis
Screening data were pre–processed by excluding values below the detection limit. We
showed that 1.25 x 102 – 5 x 105 events per 100 µL of a labeled cell type can be quan-
tified without bias in a cell mixture (Figure 2g). The detection limit was thus chosen
accordingly. Outliers occur randomly in automated liquid–handling and are typically
due to technical issues, such as the aspiration of air bubbles. To identify outliers above
the detection limit, the modified z–score was applied with a z–score of >3.5 considered
significant [29,30]. To determine differences in means, a two–sided Student’s t–test was
performed, provided that equal variances could be asserted by an F–test. To determine
significant differences between multiple means one–way analysis of variances (ANOVA)
was performed, provided that equal variances could be asserted by a Levene–test. Error
propagation was considered in all analyses [31]. Unless stated otherwise, n represents the
number of technical replicates.
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3 Results & Discussion
3.1 HTS-development and validation
We developed a fully automated screening set–up that integrates cell partitioning in
ATPS on a Tecan LHS and cell quantification and analysis at the single cell level using
HT–flow cytometry. Briefly, ATPS are prepared, and cells are added from a concentrated
stock solution. After mixing and phase separation, samples are taken from top and
bottom phase, diluted, and stained with specific antibodies to discriminate between the
respective cell populations (Fig. 1). A major concern in ATPS research is the lack
of reproducibility [32]. As shown in previous studies [6], liquid handling calibration is
essential to enable accurate and precise liquid handling, and was thus performed for
all stock solutions (Table A1). For automated liquid–handling of cells, resuspension
steps were implemented and validated regarding accuracy and precision of transferred cell
numbers, and cell viability. With optimized resuspension settings, accurate cell numbers
could be transferred in a volume of 13 µL over several resuspension cycles with good
precision (CV ≤ 7%). Cell viability was > 94% and not significantly decreased compared
to manual resuspension over 6 resuspension cycles (p>0.05) (Fig. 2a & 2b).
Sampling of top and bottom phase was performed as shown in previous work [6], and
pipetting parameters were optimized with regard to precision, accuracy, and carry–over
(Table A2 & A3). Using these pipetting parameters, we obtained variation coefficients
of < 2.1% for top phase sampling and <1.63% for bottom phase sampling. With a series
of spiking experiments, we showed that there is no detectable carry-over during bottom
phase sampling (Fig. 2c).
One of the most critical parameters in HTS–applications for ATPS research is sufficient
mixing of the viscous polymer solutions which has thus been intensively investigated in
our group [6,26]. We established that adequate mixing is possible for PEG–phosphate
ATPS with the here described setup. It has been shown that the interfacial tension and
viscosity are the main parameters influencing mixing efficiency [26]. Since the interfacial
tension of PEG–dextran ATPS is very low (1–100 µJ/m2) compared to other types of
two–phase systems [33,34] the only limiting factor might be the comparably high viscosity
of the polymers. We thus evaluated whether sufficient mixing is possible for different TLL
of PEG–dextran ATPS by evaluating if the dye methyl violet is distributed homogenously
in the sample. We showed that 8 minutes mixing time is sufficient to achieve homogeneous
dye distribution even at high TLL (Fig. 2d & 2e). In analogy to previous experiments
[26], we evaluated whether the same partitioning coefficients for methyl violet are obtained
when shaking on an orbital shaker and on an over–head shaker. The experiment was
performed at intermediate and long tie–lines, representing high viscosities. No significant
difference between partitioning coefficients was observed, and variation coefficients of the
determined partitioning coefficients were below 5% (Fig. 2f). We thus concluded that
sufficient mixing is possible under the same conditions as published before [6].
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Figure 1: Overview of the developed HTS–platform. After phase diagrams are determined in high–
throughput, ATPS are selected for the screening. ATPS are prepared in deep–well plates, and cells
are added from a concentrated stock solution, after resuspension. After mixing and phase separation,
samples are taken from top and bottom phase, diluted, and stained with an anti–CD11b–FITC antibody
to discriminate between the two cell populations. FSC-A: forward scatter peak area, SSC-A: side scatter









































































































































































Figure 2: HTS development and validation. (a–b) Evaluation of cell resuspension efficiency and impact
on cell viability. (a) Transferred cell numbers over six resuspension cycles (n=4). One–way ANOVA
showed no significant differences between mean transferred cell numbers (p> 0.05). (b) Influence of cell
resuspension on cell viability. The percentage of viable cells was determined over six resuspension cycles
and compared to manual resuspension (n=3). One–way ANOVA showed no significant changes in cell
viability (p> 0.05). (c) Evaluation of carry–over during bottom phase sampling. Top phase, spiked
with 5 x 105 CellTracker
TM
Orange CMRA stained HL–60 cells, was carefully layered on top of an equal
volume of bottom phase and sampling was performed on the LHS (n=4). Student’s t–test showed no
significant differences between spiked samples and controls (p> 0.05). ATPS: A: 4/4; B: 4/5; C: 5/7 %
(w/w) PEG 8,000/ dextran 500,000 in 0.11 M NaPi, pH 7.4. (d – f) Evaluation of mixing efficiency.
(d – e) Dye distribution over shaking time. 13 µL methyl violet stock solution was layered on top of
ATPS B & C (see above), and the plate was shaken for 8 min on the integrated orbital shaker (shaking
orbit: 3 mm, rotational speed: 1,300 rpm). Samples were taken every 60 s from the bottom of the
well and 10–fold diluted with water, using the LHS. Dye concentrations were determined by absorbance
measurement at 580 nm (n=4). (f) Partitioning coefficients (K) of methyl violet for different mixing
modes. ATPS with different TLL were prepared on the LHS, methyl violet was added, and plates were
mixed on an orbital shaker for 8 min or on an over–head shaker for 10 min (shaking radius: 100 mm,
shaking speed: 40 rpm). Partitioning coefficients (K) represent the ratio of dye concentrations between
top and bottom phase. Variation coefficients of K–values were below 5%. Data show mean values + s.d.
(n=8). Student ’s t–test showed no significant differences between partitioning coefficients in dependence
of the mixing mode (p>0.05). (g – h) Influence of cell number on multiplexed cell quantification & well–
to–well carry–over during HT–flow cytometry. (g) Quantification of a mixture of HL–60 and L929 cells.
HL–60 cells were stained with CellTracker
TM
Orange CMRA and mixed with L929 cells. A dilution series
was prepared (1 x 103 - 1 x 106 cells per mL) and quantified by HT–flow cytometry (n=3). Statistical
analysis (one–way ANOVA) of the ratio between HL–60 and L929 showed no significant changes over
the entire calibration range (p>0.05).
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Figure 2: (continued) (h) Well–to–well carry–over in HT–flow cytometry. Wells containing staining
buffer were measured directly after wells containing 105 – 106 cells per mL (n=3). (i) Influence of ATPS
components on antibody staining using no–wash staining protocols for HT–flow cytometry. Robustness
of antibody staining was investigated using an anti–CD11b–FITC antibody. After brief incubation in
top (TP) and bottom phase (BP) of ATPS B (see above), the differentiated HL–60 cells were stained and
the percentage of differentiated HL–60 cells was determined by flow cytometry (n=3). Student’s t–test
showed no significant influence of the polymers on the detection of differentiated HL–60 cells (p>0.05).
Bars represent means. CV: coefficient of variation.
3.2 Implementation of no–wash staining protocols and high–
throughput cell quantification
The easiest and most robust way to analyze and quantify cells after partitioning in ATPS
is the use of no–wash staining protocols for flow cytometry. Since the polymer solutions
have comparably high densities, cell sedimentation by centrifugation can be challenging.
In order to keep the screening as robust and versatile as possible, we established no–wash
staining protocols.
In previous work [25], we showed that flow cytometry is an excellent tool for cell quan-
tification and shows high sensitivity, robustness, and a broad working range (>3 orders
of magnitude). Moreover, we showed that the presence of different salts and polymers
(≤ 2% (w/w)) did not significantly influence cell quantification. In the present work, we
showed that the enumeration of a HL–60 and L929 cells in a mixture of both cell lines
was not biased over the entire calibration range (Fig. 2g), and without significant well–
to–well carry–over, which was determined by analyzing wells containing staining buffer
directly after wells containing defined cell numbers. The number of counted events was
well below the detection limit of 100 events, independent of the cell number (Fig. 2h).
Likewise, we showed that antibody staining is not altered in the presence of low polymer
concentrations when no–wash protocols are used (Fig. 2i). Overall pipetting accuracy
was evaluated for each screening by including PBS controls that did not contain phase
forming polymers. In average the variation coefficients of counted cell numbers were in
the range of 5 to 6% (n=8) demonstrating excellent overall pipetting accuracy, and cell
viability was ≥ 92% in all experiments, which was determined by HT-flow cytometry at
the end of each screening based on forward (FSC) and side scatter signal (SSC) analysis
(Fig.1).
3.3 Characterization of PEG–dextran ATPS
The ATPS used in this work consisted of PEG 8,000 and dextran 500,000, buffered with
isotonic concentrations of NaPi and NaCl. These conditions were chosen as they are well
described in literature. Phase diagrams were determined using a HT–approach, to select
suitable screening ranges. The binodal was determined by titration of the two polymers,
since turbidity occurs when polymer concentrations are within the two–phase region (Fig.
3a, top). Tie–lines were determined from the volume ratio of top and bottom phase by
applying the lever–arm rule (Fig. 3a, bottom). To validate the HTS–based method,
the binodal of PEG 8,000 and dextran 500,000 was compared with a dataset determined





























































































Figure 3: Determination of phase diagrams of polymer–polymer ATPS. (a) HT–method for determina-
tion of binodals. Binodals are constructed by preparing increasing concentrations of the phase forming
polymers on the Tecan LHS. After shaking, the binodal can be determined by turbidity analysis. The
binodal is then fitted to equation 1 using least–square regression. Tie–lines are determined using the
lever–arm rule, which states that the volume ratio of top and bottom phase (VT/VB) equals the distance
ratio (L2/L1) between the initial system point and the intersects between tie–line and binodal. ATPS are
prepared at distinct points above the binodal and volume ratios of top and bottom phase are measured.
(b) Binodal and tie–line data of PEG 8,000–dextran 500,000. Data sets determined by HTS and manual
titration were compared to data published by Albertsson et al., 1986 (top panel). The fitted curve was
calculated based on HTS–data. Dashed lines represent 95% prediction bounds of the fit. The following
coefficients of equation 1 were calculated: a: 7.23 (6.98, 7.48), b: -0.318 (-0.344, -0.292), c: -0.00027
(-0.00032, -0.00021), with a Pearson r2 of 0.996. 95% prediction bounds of the fit coefficients are shown
in parentheses. Tie–lines are shown in the bottom panel.
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The HTS–dataset was fitted to equation 1, as described by Merchuk [27].
y = a× e(b×x0.5+c×x3) (1)
As shown in Fig. 3b, we found an excellent congruence between the three data sets.
Both, the dataset determined by manual titration and the dataset from literature were
found within the 95%–confidence interval of the HTS–dataset. We only observed slight
deviations of the dataset determined by Albertsson, 1986, at very low dextran concentra-
tions. This is due to missing data points in the HTS–dataset at very low concentrations.
At very low concentration of either polymers, visual discrimination between one and
two–phase region becomes increasingly difficult. Nonetheless, shape and location of the
binodal could be determined with good accuracy. In addition TLL, tie–line slopes (STL),
and phase compositions determined here, were in excellent agreement with literature data.
As shown before [35–37], tie–line slope increased slightly with increasing TLL. Phase com-
positions of the ATPS used in this work are summarized in Table 1. In addition, the
influence of physiological concentrations of phosphate and NaCl was investigated, since
even low salt concentrations have been shown to alter shape and position of binodal and
tie–lines. As described by Walter [21], the addition of physiological concentrations of
phosphate results in a minor shift of the binodal towards lower polymer concentrations,
while NaCl did not alter shape or location of the binodal (data not shown). The influ-
ence on TLL was however minimal which was in excellent agreement with literature data
[21].The physicochemical properties of ATPS are highly dependent on the TLL. With
increasing TLL, the polymer concentration in the respective phase increases, along with
the densities. At the same time, the concentration and density difference, as well as
the interfacial tension between the phases increases [34]. Thus, determination of phase
diagrams is essential to develop downstream processing strategies using ATPS.
Table 1: Summary of phase compositions, tie–line lengths (TLL), and slope of tie–line (STL) at RT.
Total system composition Bottom phase composition Top phase composition TLL STL
PEG dextran PEG dextran PEG dextran
[%(w/w)] [%(w/w)] [%(w/w)] [%(w/w)] [%(w/w)] [%(w/w)] [%(w/w)]
4 4 2.3 8.8 4.7 1.9 7.3 –0.35
4 5 1.8 11.0 5.5 1.0 10.7 –0.37
5 7 0.5 17.8 7.9 0.00045 19.3 –0.41
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3.4 Separation of HL–60 cells after partial granulocytic differen-
tiation
The aim of this first case study was to investigate the influence of TLL, salt composi-
tion, and pH on the resolution of partially differentiated HL–60 cells, and we screened
for ATPS compositions that are capable of separating undifferentiated and differentiated
HL–60 cells. The promyelocytic cell line HL–60 can be differentiated towards granulocytes
by DMSO treatment. The differentiation is accompanied by changes in cell morphology,
growth rate, and cell–surface antigen expression [38,39]. As cells enter the granulocytic
differentiation pathway, proliferation is dramatically decreased [38], which was shown by
monitoring cell growth and viability over the differentiation period (Fig. 4). In addi-
tion, DMSO–mediated differentiation results in increased granularity and decreased cell
size, which is represented by a decrease of forward and side scatter signal (Fig. 4a). In
addition, we analyzed CD11b–expression, which is upregulated after the promyelocytic
stage (Fig. 4b). The differentiation efficiency was typically between 40 and 60%, which
is ideal for separation studies, as we have two distinct cell populations in similar quan-
tities. In our screenings we analyzed CD11b–expression to discriminate between the two
cell populations. It is well established that ATPS are an excellent tool to separate cells
according to differences in physicochemical cell surface properties, i.e. cell surface charge
and membrane lipid composition [21,35]. The multitude of morphological and functional
changes during differentiation of HL–60 cells can thus be exploited for ATPS-mediated
cell separation.
In contrast to smaller biomolecules such as proteins and nucleic acids, cells partition
between one of the bulk phases, i.e. top or bottom phase, and the interface, depending
on the ATPS composition. The interfacial tension, and thus the TLL, plays a major
role in cell partitioning in ATPS, since the interfacial tension acts to minimize the in-
terfacial area. The adsorption of cells and other particles to the interface reduces the
interfacial area, and thus the total free energy of the system. As a consequence, parti-
tioning into either phase can only take place when the interaction with the cell surface is
strong enough to ”pull” the cells out of the interface. The higher the interfacial tension,
the stronger interactions are required to enable partitioning to either of the bulk phases
[21,34]. To date, two main factors in ATPS–mediated cell separation have been identified:
surface charge and membrane lipid composition, and cell separation based on these fac-
tors can be achieved in dependence of the salt composition. Salts with polyvalent anions,
e.g. phosphate, have a higher affinity for the dextran–rich bottom phase, while salts of
halides, for example NaCl, partition equally between the phases. Unequal partitioning
of a salt results in an interfacial electrostatic potential difference (Donnan potential),
and molecules partition according to their charge in such ATPS [21,40–42]. At moderate
interfacial tensions cells can thus be separated based on differences in surface charge in
PEG–dextran ATPS containing phosphate (charge–dependent partitioning). Since cells
have a negative net surface charge, they partition into the top phase in ATPS containing
phosphate [20,42]. Further, cell partitioning according to membrane lipid–composition
can be achieved in ATPS with low interfacial tension, i.e. close to the critical point,
containing salts that partition equally between the two phases (charge–independent par-
titioning) [43].



































































Figure 4: Granulocytic differentiation of the promyelocytic cell line HL–60. HL–60 cells were differ-
entiated towards granulocytes by DMSO–treatment. Differentiation was assessed by flow cytometric
analysis of cell morphology and cell–surface antigen expression after 7 days of DMSO–treatment. (a)
DMSO–mediated differentiation towards cell types of the granulocytic lineage results in increased gran-
ularity and decreased cell size, represented by a decrease of forward (FSC) and side scatter (SSC) signal.
(b) Discrimination between undifferentiated and differentiated HL–60 cells was performed by analysis of
CD11b–expression which is up–regulated after the promyelocytic stage. (c – d) Proliferation and cell
viability during DMSO–mediated granulocytic differentiation. (c) Growth curves and (d) viability of
untreated and DMSO treated HL–60 cells over seven days. Cell numbers and viability were determined


















































Figure 5: HT–partitioning analysis of CD11b–positive and CD11b–negative HL–60 cells in charge–
sensitive ATPS in dependence of salt composition, pH and TLL, after DMSO–mediated differentiation.
Cell partitioning was analyzed in PEG 8,000–dextran 500,000 ATPS with varying ratios of NaPi and
NaCl. While the overall salt concentration was kept at isotonic concentrations, the molar ratio of NaPi
and NaCl was varied (50%, 65%, 100% mM NaPi). (a) At an intermediate TLL of 10.7 (4% PEG, 5%
dextran) at pH 6.6, 7.0, and 7.4, and (b) at three different TLL (4% PEG, 4% dextran; 4% PEG, 5%
dextran; 5% PEG, 7% dextran) at pH 6.6. Heat maps represent the mean percentage of live cells in each
phase (n=4).
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Stendahl et al. investigated the changes in hydrophobic surface properties of HL–60 cells
during DMSO–mediated differentiation [44]. They showed that DMSO–treated HL–60
cells have a higher affinity to the top phase in charge–insensitive PEG –dextran ATPS. In
analogy to these studies we investigated charge–independent partitioning of differentiated
HL–60 cells (4% PEG 8,000, 4% dextran 500,000, in 0.14 M NaCl) and detected 6.5%
(2.6%) and 13.7% (4.9%) (mean (s.d.), n=4) of total CD11b–negative and CD11b–positive
HL–60 cells in the top phase, respectively. In addition, we determined the fold change
of the percentage of CD11b–positive HL–60 cells in the top phase (TP) compared to the





Fold enrichment of CD11b–positive HL–60 cells in the top phase (1.30 (0.03) (mean (s.d.),
n=4)) was highly significant (p< 0.001) and in excellent agreement with literature [44].
We further studied changes in charge–associated surface properties of HL–60 cells by
investigating the resolution of CD11b–positive and CD11b–negative HL–60 cells after
DMSO–mediated differentiation in charge–sensitive ATPS, in dependence of TLL, salt
composition, and pH. We chose ATPS with varying ratios of phosphate and NaCl, at iso-
tonic concentrations, at three different TLL and different pH–values. ATPS–compositions
are summarized in Table A4, and the results of this study are summarized in Fig. 5.
At intermediate TLL of 10.7% (w/w), the cells partitioned increasingly to the top phase
with increasing phosphate concentration, and we observed resolution of the two cell pop-
ulations according to their surface charge. We found that CD11b–negative HL–60 cells
have lower net surface–charge than CD11b–positive HL–60 cells, and consequently lower
partitioning ratios in charge–sensitive ATPS (Fig. 5a). We further observed a slight
pH–dependence, with increasing cell partitioning to the top phase with increasing pH
(Fig. 5a). This is most likely due to an increase in the ratio of di– to mono–basic phos-
phate [21,35]. Since the electrostatic potential difference increases with increasing TLL,
we observed excellent resolution of CD11b–positive and CD11b–negative HL–60 cells at
high phosphate concentrations at intermediate TLL (Fig. 5b, middle), but less close
to the critical point (Fig. 5b, right). Even though the electrostatic potential difference
increases with increasing TLL we observed no partitioning into the top phase at long TLL
of 19.3% (w/w). This is due to the fact that at some distance from the critical point,
the increase in interfacial tension offsets the increase in electrostatic potential difference
[21]. At high phosphate concentrations both cell populations thus accumulated at the
interface. With decreasing phosphate concentrations, however, we observed increased
partitioning into the bottom phase and we did not observe differences in partitioning of
CD11b–positive and CD11b–negative HL–60 cells at higher TLL (Fig. 5b, left).
In summary, differences in partitioning varied with TLL and phosphate concentration,
and can be selected accordingly for multi–step separations. The observed trends were in
excellent agreement with literature data [21,35]. To select ATPS that enable maximal
resolution in a multi–stage purification process, we calculated partitioning ratios (K),











where P represents the fraction of cells in the top phase and I the fraction of cells at
the interface. We investigated Q in dependence of K to select ATPS that give maximal
resolution (Fig. 6a). We were able to obtain partitioning ratios over more than two
orders of magnitude and Q–values of up to 5. This type of plot provides a simple means
to select systems with maximal differences in partitioning ratios at different K–values.
Countercurrent distribution (CCD) is a well–established method in liquid–liquid extrac-
tion and has been successfully used in cell separation [21,23]. In CCD the top phase is
transferred stepwise, while the bottom phase is retained. After transfer of the top phase,
the ATPS are mixed and allowed to separate by gravity. Depending on the application,
the interface can either be transferred or retained. As cells partition between either of
the bulk phases and the interface, the interface is retained when cells partition between
top phase and interface, and transferred when the cells partition between interface and
bottom phase. Cells that partition largely into the top phase, thus, move faster through
the CCD–device than cells that partition largely to the interface, which enables separa-
tion (Fig. 6b). Based on the data shown in Fig. 6a, CCD–curves can be predicted by




r(1 − P )n-r (5)
where F represents the fraction of the total cell population appearing in each theoret-
ical cavity (r) of the CCD–apparatus, and n represents the total number of transfers.
We chose four conditions with different K–values and the corresponding highest Q–value
(Fig. 6a), and calculated theoretical CCD–experiments with 30 and 60 transfers, based
on the respective P–values of CD11b–positive and CD11b–negative cells (Fig. 6c).
Our data show that K–values around 1 enable optimal resolution of CD11b–positive and
CD11b–negative HL–60 cells by CCD. As described before, CCD–curves are skewed at
very high and very low K–values, and resolution is decreased, with the exception of
ATPS, where 100% of the target cell type and <100% of the contaminants are found in
one of the phases [21]. In this case excellent purities and yields can be obtained, since
contaminants can be washed out with minimal loss of target cells. Maximal resolution
of CD11b–negative and CD11b–positive HL–60 cells can be obtained by using ATPS 3
in a CCD–experiment. The modeling data indicate that complete peak separation is
possible when performing 60 transfers, and > 99.9% of CD11b–positive HL–60 cells can
be recovered with > 99% purity. Even with 30 transfers, more than 93% yield at > 99%
purity is possible, reducing the processing time by half. Further optimization of separa-
tion conditions at TLL between 7 and 11, at salt ratios between 70 and 100% sodium
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Figure 6: Selection of separation conditions for CD11b–negative and CD11b–positive HL–60 cells based
on CCD–modeling. (a) The partitioning ratio of CD11b–negative cells (KCD11b–negative) was plotted
against the quotient of the partitioning ratios of CD11b–negative and CD11b–positive HL–60 cells (Q)
obtained from the data shown in Fig. 4. Systems selected for the calculation of CCD–curves are indicated
and numbered. ATPS 1–3: 4% PEG, 5% dextran, with ATPS 1: 70% NaPi; pH 7.0, ATPS 2: 70% NaPi,
pH 7.4; ATPS 3: 100% NaPi, pH 7.4, and ATPS 4: 4% PEG, 4% dextran, 50% NaPi, pH 6.6. Data
show mean values ± s.d. (n=4). (b) Scheme of the CCD–principle for ATPS in which cells partition
between top phase and interface. The top phase is transferred stepwise. Between the transfers ATPS are
mixed and phases are separated by gravity. Blue and red circles represent two cell types. The cell type
represented by the blue circles has a higher partitioning ratio than the cell type represented by the red
circles. (c) CCD–model with 30 (left panel) and 60 (right panel) theoretical transfers for the four ATPS
indicated in (a). Theoretical yields of CD11b–positive HL–60 cells were calculated for a target purity of
> 99%.
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phosphate and at pH–values between 7.0 and 7.5, could result in separation conditions
where complete separation can be obtained with even fewer number of transfers.
After identifying ATPS with maximal possible resolution at a given number of transfers,
resolution vs. processing time can be modeled and final purification conditions can be
chosen for a specific purification task. It should be noted that partitioning ratios of cells
are highly dependent on vessel geometry, fill volume, mixing efficiency, and phase separa-
tion time. Thus, these conditions need to be identical in batch– and CCD–experiments,
otherwise predicted CCD–curves will not be accurate [21]. The strength of the here de-
scribed HTS–platform is that it is extremely versatile and applicable for most labware
types, which enables direct optimization of all these parameters in high–throughput.
Depending on target yield and purity, as well as maximal processing time for a specific
application, separation conditions can be further optimized by varying salt concentra-
tions, pH, and TLL. The analysis of additional factors such as polymer molecular weight
and the investigation of a variety of salts, additives, and polymers, will enable us to
identify the main factors influencing cell separation in ATPS. Such large and systematic
screenings combined with CCD–modeling will enable fast and directed development of
purification strategies for cell based–products.
3.5 Influence of polymers on viability and functionality
PEG–dextran ATPS are generally regarded to offer physiological conditions for cell pu-
rification [21], and both polymers are used in many medical applications. However, PEG
and dextran have also been associated with cell fusion, and effects on live cells are not
fully characterized [21,45,46]. Therefore, the polymers might have adverse effects on cer-
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Figure 7: Influence of PEG and dextran on cell proliferation and granulocytic differentiation. HL–60
cells were added to an ATPS containing 5% dextran 500,000, 4% PEG 8,000, and 0.14 M NaCl, and
incubated for 30 min at room temperature (red). Control cells (blue) were untreated. After washing
the cells with PBS, 50% of the cells were resuspended in differentiation medium (a) and 50% in culture
medium (b). After culturing the cells for seven days, flow cytometric analysis of CD11b–expression was
performed as described. The histograms show overlays of treated samples and controls. The experiment
was performed in biological triplicates. Proliferation was analyzed by determining the number of viable
cells after the culture period. Bars represent mean values (n=3 biological replicates). Statistical analysis
(Student’s t–test) of viable cell numbers and percentage of CD11b–positive cells showed no significant
differences between cells incubated in ATPS and PBS controls (p> 0.05).
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Since differentiation of HL–60 cells is triggered by relatively unspecific factors, such
as the presence of polar solvents, they are an excellent model to evaluate potential ad-
verse effect of PEG–dextran ATPS on functionality and viability. Changes in membrane
permeability, caused by the presence of the polymers is likely to induce differentiation or
cell death. We thus evaluated if viability and differentiability of HL–60 cells is influenced
after ATPS–treatment, or if differentiation is induced. Investigation of cell growth, dif-
ferentiability and differentiation stage was not significantly (p>0.05) altered compared
to untreated cells (Fig. 7). These results indicate that cell purification in ATPS does
not interfere with cell viability and functionality. However, more comprehensive studies
will have to be performed to confirm this assumption.
4 Conclusion & Outlook
We have developed and validated an automated robotic screening that enables HT-cell
partitioning analysis in ATPS. We demonstrated that this setup enables fast and sys-
tematic investigation of factors influencing cell partitioning. We further showed that
CCD–models can be used to design purification processes based on screening data, and
we successfully designed a purification process for CD11b–positive HL–60 cells. Due to
the versatility of Tecan LHS, the screening platform can easily be adapted to countless
applications. Up– and downscaling can be performed by simply changing the labware
type, and the influence of settling time, mixing intensity, fill volume, and vessel geometry
can be studied. This enables the simultaneous optimization of multiple parameters for
purification in a CCD–device. Likewise, numerous analytical methods, such as various
PCR–techniques, ELISAs, and high–content screening can be directly integrated in the
screening process. The use of design of experiments (DoE) will enable us to simultane-
ously investigate the effects of numerous parameters, and optimize separation conditions
for various applications. Future exploitation of this platform will, thus, enable us to
gain a more detailed understanding of the mechanisms underlying cell partitioning in
ATPS. We expect that this technology will facilitate faster, cheaper, and more directed
downstream process development for cell–based therapeutics.
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Table A2: Pipetting parameters for top and bottom phase sampling. Parameters for bottom phase
sampling are stated in parentheses if differing from top phase sampling. STAG: System trailing airgap;
TAG: trailing airgap; AG: Airgap which is dispensed before sample aspiration; WP: volume pipetted
into wash plate before sample is dispensed, to reduce carry–over. 1Sample+LAG & TAG.
No of Plunger steps [–] Speed [µLs-1]
Aspiration (incl. excess volume) 90 (149) 5
Dispense (WP) 0 (32) 5
Dispense 1491 (88) 5
STAG 150 (150) 70
TAG 30 (0) 70
AG 0 (32) 70
Table A3: Summary of pipetting accuracy and precision for different TLL determined by petting on
an analytical balance. Std: standard deviation (n=8); CV: coefficient of variation. Mean volumes were
calculated by multiplying the pipetted masses with the phase densities.
ATPS 4% (w/w) PEG 8,000/ 4%
(w/w) dextran 500,000
4% (w/w) PEG 8,000/ 5%
(w/w) dextran 500,000
5% (w/w) PEG 8,000/ 7%
(w/w) dextran 500,000
TLL 7.3 10.8 19.3
Phase top bottom top bottom top bottom
Mean volume [µL] 29.98 29.29 30.22 29.48 30.24 29.45
Std [µL] 0.40 0.46 0.64 0.46 0.68 0.48
CV [%] 1.35 1.57 2.11 1.57 2.24 1.63
Table A4: Summary of ATPS–compositions.
ATPS PEG 8,000 dextran 500,000 sodium phosphate sodium chloride pH sodium chloride
# [%(w/w)] [%(w/w)] [mM] [mM] [–] [%]
1 4 4 110 0 6.6 0
2 4 4 90 50 6.6 35
3 4 4 70 70 6.6 50
4 4 5 110 0 6.6 0
5 4 5 90 50 6.6 35
6 4 5 70 70 6.6 50
7 4 5 110 0 7.0 0
8 4 5 90 50 7.0 35
9 4 5 70 70 7.0 50
10 4 5 110 0 7.4 0
11 4 5 90 50 7.4 35
12 4 5 70 70 7.4 50
13 5 7 110 0 6.6 0
14 5 7 90 50 6.6 35
15 5 7 70 70 6.6 50
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Abstract
The availability of clinical–scale downstream processing strategies for cell–based products
presents a critical juncture between basic research and clinical development. Aqueous two-
phase systems (ATPS) facilitate the label–free, scalable, and cost–effective separation of
cells, and are a versatile tool for downstream processing of cell–based therapeutics. Here,
we report the application of a robotic screening platform that enables high–throughput
cell partitioning analysis in ATPS. We investigated the influence of polymer molecular
weight and tie–line length on the resolution of five model cell lines in charge-sensitive
PEG–dextran ATPS. We show, how these factors influence cell partitioning, and that the
combination of low molecular weight PEGs and high molecular weight dextrans enable
the highest resolution of the five cell lines. Furthermore, we demonstrate that the sepa-
rability of each cell line from the mixture is highly dependent on the polymer molecular
weight composition and tie–line length. Using a countercurrent distribution model we
demonstrate that our screenings yielded conditions that enable the isolation of four of
the five cell lines with high purity (>99.9%) and yield.
Keywords: high–throughput screening, cell separation, aqueous two–phase systems
(ATPS), charge–dependent partitioning, tie–line length, polymer molecular weight
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1 Introduction
Cell–based therapeutics for a variety of diseases and from a variety of cell sources have
made their way to clinical trials. The availability of clinical–scale downstream processing
strategies for cell–based products represents a crucial juncture between basic research
and clinical development. For clinical applications, cell–based products often need to
be enriched to high purities, since certain contaminants can cause severe side effects,
such as teratoma formation or graft–versus–host–disease (GvHD) [1–6]. The most widely
applied cell purification methods are based on affinity–purification. These methods, how-
ever, require large amounts of clinical–grade antibodies, presenting a significant cost–
factor [5,7,8]. Likewise, antibody–labels remaining on the cell surface, pose considerable
regulatory obstacles for the treatment of patients, as they may cause adverse reactions
[4,5]. Aqueous two–phase systems (ATPS) present a gentle, cost–effective, scalable, and
label–free method for cell purification. ATPS are aqueous solutions consisting of one
or more compounds, e.g. different polymers, which form two immiscible phases above
a certain threshold (e.g. concentration, temperature). The two phases have distinct
physicochemical properties, consequently, biomolecules partition between them accord-
ing to their respective physicochemical properties. By now, they are well established in
downstream processing of biopharmaceuticals, such as protein– and DNA–based phar-
maceuticals [9–11]. Polyethylene–glycol (PEG)–dextran ATPS have been successfully
used to separate cells according to their surface properties, and it is well established
that ATPS facilitate the separation of different cell types with high selectivity and res-
olution [10,12]. In multi–stage experiments, e.g. countercurrent distribution (CCD),
even complex cell mixtures were effectively separated [10,13]. While the mechanisms
underlying cell partitioning in ATPS are not fully understood, two main factors in cell
separation have been identified: surface charge and membrane lipid composition. Surface
charge–dependent cell separation is possible in ATPS containing isotonic concentrations
of phosphate (charge–sensitive ATPS), and partitioning coefficients could be correlated
to the cells electrophoretic mobility. Charge–independent cell separation can be achieved
in ATPS containing isotonic concentrations of NaCl (charge–insensitive ATPS), and par-
titioning coefficients have been correlated with the cells membrane lipid composition, i.e.
membrane hydrophobicity [10,12,14,15]. These phenomena are based on different parti-
tioning properties of the respective salts. While sodium chloride partitions almost equally
between the phases, sodium phosphate has a stronger affinity to the dextran–rich bot-
tom phase, resulting in an interfacial electrostatic potential difference (Donnan potential)
[16,17]. The Donnan potential is highly dependent on salt–composition, tie–line length
(TLL), polymer type and molecular weight [10,12,18]. At the same time, TLL and poly-
mer molecular weight significantly influence cell partitioning in the absence of a Donnan
potential [10,12]. A key factor in cell partitioning is the interfacial tension [19], which is
directly correlated with TLL and polymer molecular weight [20]. The interaction of all
these parameters in respect to cell partitioning and the resolution of different cell popula-
tions is however unclear. In previous work, we developed an integrated high–throughput
screening (HTS)–platform for the analysis of cell partitioning in ATPS. We investigated
the influence of TLL, salt composition, and pH on the resolution of several model cell
lines and described strategies for fast and directed HT–downstream process development
[21]. In this work, we used this HTS–platform to investigate the influence of the PEG
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and dextran molecular weights in dependence of the TLL on cell partitioning in ATPS.
Using different CellTrackerTM dyes in a combinatorial fashion for cell barcoding, enables
multiplexing of several cell lines in a single experiment, and results in a substantial de-
crease in time and material consumption. Moreover, batch variability can be eliminated
by analyzing numerous cell lines in the same experiment. The present work describes how
TLL in dependence of the polymer molecular weight influence the resolution of five bar-
coded model cell lines in charge–sensitive ATPS, characterizes suitable screening ranges
and shows how these data can be used to design purification strategies for the various
cell populations.
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2 Materials & Methods
2.1 Disposables
For ATPS preparation, 1.3 mL deep well plates (Nalgene Nunc, Rochester, NY, cat.
260252) and for flow cytometry, 96–well U–bottom plates (BD FalconTM , Franklin Lakes,
NJ, cat. 353910) were used. Polypropylene flat–bottom microplates (Greiner Bio–One,
Kremsmünster, Austria, cat. 655261) were used for all other purposes.
2.2 Software and data processing
Evoware 2.5 SP2 standard (Tecan, Crailsheim, Germany) was used to control the Tecan
Freedom Evo 200 liquid handling station. Advanced applications such as sampling and
cell resuspension were realized via visual basic scripts that were directly fed into Evoware.
For data storage Excel 2013 (Microsoft, Redmond, WA, USA) was used. Matlab R2014a
(The MathWorks, Natick, ME, USA) and Excel 2013 were used for data evaluation and
visualization. Statistical data analysis was performed with Matlab R2014a. The BD
LSR Fortessa Cell Analyzer was controlled using BD FACSDiva 8.0 (BD Biosciences, San
Jose, CA, USA). In addition, BD FACSDiva 8.0 was used to calculate the compensation
of spectral overlap and for raw data analysis. Flow cytometry data visualization was
performed with Flow Jo V10 (Tree Star, Ashland, OR, USA).
2.3 Preparation of buffers and stock solutions
For the preparation of buffers and stock solutions ultra–pure water (0.55 µS/cm) obtained
from an Arium R© proUV water system (Sartorius Stedim Biotech, Goettingen, Germany)
was used. Stock solutions of 2% and 20% dextran 70,000 (Carl Roth Kalrsruhe, Germany,
cat. 9228.2, Batch No.: 215229323), 2% and 20% dextran 500,000 (Pharmacosmos A/S,
Holbæck, Denmark, cat. 5510 0500 9007, Batch No.: HT3229), 40% PEG 4,000 (Merck
Millipore, Billerica, MA, USA, cat. 8.17066.5000, Batch No.: K46660006524), 30% PEG
8,000 (Sigma Aldrich, St. Louis, MO, USA, cat. P2139, Batch No.: 059Ko121), and
20% PEG 20,000 (Sigma Aldrich, cat. 95172–250G–F, Batch No.: BCBP5677V) were
prepared in ultra–pure water and dissolved on a magnetic stirrer overnight. 500 mM
sodium phosphate (NaPi) buffer stock solutions with pH 6.6, and 7.4 were prepared as
described before [21]. Sodium chloride (NaCl) (Merck Millipore) was prepared as a 500
mM stock solution. Sterile filtration (Ø 0.22 µm) was performed for all buffers and stock
solutions. Polymer solutions were stored at 4◦C whereas buffers were stored at room
temperature. The flow cytometry staining buffer was prepared directly before use and
consisted of phosphate buffered saline (PBS) (Life TechnologiesTM , Carlsbad, CA, USA)
supplemented with 2 mM EDTA (Life TechnologiesTM) and 0.5% bovine serum albumin
(BSA) (Miltenyi Biotech, Bergisch Gladbach, Germany).
2.4 Cell culture
Unless otherwise stated cell culture reagents were purchased from Life TechnologiesTM .
The murine fibroblast cell line L929 was purchased from CLS (Cell lines Service Eppel-
heim, Germany, cat. 400260), and the rat ileum cell line IEC–18 was purchased from
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ATCC (cat. CRL–1589). The human lung carcinoma cell line A549 (ATCC, cat. CCL–
185) and the human colorectal carcinoma cell line HCT 116 (ATCC, cat. CCL–247)
were a gift from Prof. Hartwig’s lab. The rat beta–cell line INS–1E [22] was kindly
provided by Prof. Maechler from the Department of Cell Physiology and Metabolism at
the University of Geneva Medical Centre, Switzerland. All cell lines were propagated at
37◦C in a humidified 5% CO2 incubator. L929, A549 and HCT 116 cells were grown in
DMEM with GlutaMAX supplemented with 10% FBS and 1% Penicillin/ Streptomycin.
IEC–18 cells were cultivated in DMEM with GlutaMAX supplemented with 5% FBS, 1%
NEAA, 1% Penicillin/ Streptomycin and 0.1 U per mL bovine insulin (Sigma Aldrich,
cat. I1882). INS–1E cells were cultivated in RPMI 1640 with GlutaMAX supplemented
with 10% FBS, 1% sodium pyruvate, 1% Penicillin/ Streptomycin, 10 mM HEPES and
50 µM beta mercaptoethanol (Sigma Aldrich). All cell lines were split every 3–4 days to
a concentration of 2 x 104 cells per cm2 for a maximum of 20 passages, with the exception
of INS–1E which were seeded at a concentration of 7 x 104 cells per cm2. In order to
obtain maximal reproducibility between different screenings, all cell lines were seeded at
a density of 2.7 x 105, 48 hours prior to the screening.
2.5 Cell barcoding and viability staining
In order to enable multiplexing of several cell lines and eliminate inter–experimental vari-
ability, the five cell lines were stained with different CellTrackerTM dyes (Life Techno-
logiesTM) in a combinatorial fashion. For staining, cells were trypsinized and resus-
pended in serum–free medium to a final concentration of 2 x 106 cells per mL. The
CellTrackerTM dyes were added to a final concentration of 3 µM for CellTrackerTM Violet
BMQC, 0.2 µM for CellTrackerTM Green CMFDA, and 0.05 µM for CellTrackerTM Deep
Red, respectively. The cells were stained at 37◦C for 30 minutes and subsequently resus-
pended in culture medium and incubated at 37◦C for 20 minutes to inactivate unbound
dye molecules. Prior to flow cytometric analysis, cells were stained with the viability dye
7–AAD (Biolegend, San Diego, CA, USA), according to the manufacturer’s instructions.
Dead cells were gated using heat inactivated controls (70◦C, 10 minutes).
2.6 Cell quantification using high–throughput flow cytometry
Flow cytometric cell quantification was performed as previously described [21].
2.7 Liquid–handling calibration
Liquid handling calibration was performed for all buffers and stock solutions as described
previously [21]. Calibration was performed in the range of 50–1,000 µL. Variation co-
efficients were below 1.6% for all aqueous solutions and below 3% for the more viscous
polymer solutions.
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2.8 HT–binodal and tie–line determination
A HTS–method for binodal determination based on could–point titration has previously
been established in our group and was performed as described [21].
2.9 Automated high–throughput screening of cell partitioning in
aqueous two–phase systems
The automated HTS–method was used as described in a previous publication [21]. The
entire HTS was performed on a Tecan Freedom Evo R© 200 liquid–handling station (LHS).
Subsequently, the sample plates were transferred to the high–throughput sampler of the
BD LSR Fortessa for cell quantification and analysis. ATPS were prepared in a 1.3 mL
96–well plate with a final volume of 637 µL. After mixing and addition of cells (1 x 106
cells per well), phases were allowed to settle by gravity (20 minutes, RT) and sampling
was performed as previously described. During the sampling procedure samples were 5–
fold diluted in staining buffer. After adding an equal volume of staining buffer containing
7–AAD for viability staining and incubation for 10 minutes at RT in the dark, flow
cytometric analysis was performed.
2.10 Statistical data analysis
Pre–processing of screening data was performed as described in previous work [21]. A
two–sided Student’s t–test was performed to determine differences in means, provided
that equal variances were asserted by an F–test. Error propagation was considered
throughout our analyses [23].
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3 Results
We previously developed a fully automated screening set–up that integrates cell parti-
tioning in ATPS on a Tecan liquid–handling station and cell quantification and analysis
at the single cell level using high–throughput flow cytometry [21]. In the present study
we investigated the influence of PEG and dextran molecular weight and TLL on the res-
olution of five cell lines in charge–sensitive ATPS. The following cell lines were chosen
for this study: the murine fibroblast cell line L929, the rat ileum cell line IEC–18, the
human lung carcinoma cell line A549, the human colorectal carcinoma cell line HCT 116,
and the rat beta–cell line INS–1E. Due to their different origins, we expected these cell
lines to differ significantly in their cell surface properties. We used a barcoding strategy
that enabled multiplexing of several cell lines in a single experiment (Figure 1a). By
using three different CellTrackerTM dyes in a combinatorial fashion, the cell lines were























Figure 1: Cell barcoding for multiplexing of partitioning analysis in ATPS. (a) Scheme of the barcod-
ing strategy. Several cell lines are stained with CellTracker
TM
dyes in a combinatorial fashion and
pooled, before HT–partitioning analysis in ATPS. Cell quantification and analysis is performed by
HT–flow cytometry. After data deconvolution, the partitioning coefficients of each cell type can be
determined. (b) Efficient labelling of five cell lines with three CellTracker
TM
dyes. A549 cells were
stained with CellTracker
TM
Green CMFDA and CellTracker
TM
Deep Red, INS–1E cell were stained with
CellTracker
TM
Deep Red, IEC–18 cells were stained with CellTracker
TM
Deep Red and CellTracker
TM
Vi-
olet BMQC, HCT 116 cells were stained with CellTracker
TM
Violet BMQC, and L929 cells were stained
with CellTracker
TM
Green CMFDA and CellTracker
TM
Violet BMQC.
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Spill–over between barcoded cell lines can result in inaccurate analysis of cell parti-
tioning, however, this was not observed here. We determined that spill–over was < 0.1%
in all experiments. The gating–strategy used for data deconvolution is shown in Figure
2. Partitioning coefficients were calculated based on the live cell counts of each cell line.
Cell viability was high throughout the screening (> 98% viable cells), and comparable
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Figure 2: Deconvolution method for barcoded cell lines. Single cells are gated for CellTracker
TM
Violet





Deep Red staining. The live cell population of each cell line was the gated based on
7–AAD staining. FSC–A: forward scatter peak area, SSC–A: side scatter peak area, FSC–H: forward
scatter peak height.
3.1 Characterization of PEG–dextran ATPS
Phase diagrams are essential to determine suitable screening ranges in ATPS research,
since they enable the selection of suitable volume ratios and TLL. The ATPS used in this
work consisted of different combinations of PEG 4,000, 8,000, and 20,000, and dextran
70,000 and 500,000, buffered with isotonic concentrations of sodium phosphate. Phase di-
agrams were determined using a HTS–method described in previous studies [24](Figure
3 & Table 1). Binodal curves were fitted to equation 1 using least square regression.
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Figure 3: Phase diagrams of different PEG and dextran molecular weights. Blue circles represent
binodal data points determined by HTS cloud point titration. Fit parameters of equation 1 with 95%
prediction bounds and Pearson’s r2 are shown in parentheses. (a) PEG 4,000 and dextran 70,000 (fit
parameters: a: 12.17 (11.88 / 12.46), b: –0.27 (–0.29 / –0.25), c: –0.00010 (–0.00012 / –0.000075), r2
of 0.998), (b) PEG 4,000 and dextran 500,000 (fit parameters: a: 9.96 (9.3 / 10.62), b: –0.28 (–0.33 /
–0.24), c: –0.00011 (–0.00017 / –0.00005), r2 of 0.972), (c) PEG 8,000 and dextran 70,000 (fit parameters:
a: 10.41 (9.92 / 10.89), b: –0.35 (–0.40 / –0.31), c: –0.00019 (–0.00026 / –0.00012), r2 of 0.993), (d)
PEG 8,000 and dextran 500,000 (fit parameters: a: 7.23 (6.98 / 7.48), b: –0.32 (–0.34 / –0.29), c:
–0.00027(–0.00032 / –0.00021), r2 of 0.996), (e) PEG 20,000 and dextran 70,000 (fit parameters: a: 9.04
(8.43 / 9.65), b: –0.49 (–0.56 / –0.42), c: -0.00051 (-0.00084 / -0.00018), r2 of 0.992), (f) PEG 20,000 and
dextran 500,000 (fit parameters: a: 6.44 (5.82 / 7.05), b: –0.55 (–0.64 / –0.46), c: –0.00057 (–0.00094
/ –0.00019), r2 of 0.987). 95% prediction bounds of the fit parameters are shown in parentheses. (g–h)
Overlay of binodal fits.























































Figure 4: Influence of cell barcoding on partitioning in charge–sensitive and charge–insensitive ATPS
at different TLL (# 1: 4% PEG 8,000, 4% dextran 500,000, 0.01 M NaPi, 0.138 M NaCl, pH 6.6, TLL:
6.9; # 2: 4% PEG 8,000, 4% dextran 500,000, 0.11 M NaPi, pH 7.4, TLL: 6.9; # 3: 4% PEG 8,000, 5%
dextran 500,000, 0.11 M NaPi, pH 7.4, TLL: 10.4). Two of the cell lines were barcoded with different
CellTracker
TM
dyes and mixed with an equal number of unstained cells of the same cell line. HCT 116
(a) was stained with Cell Tracker
TM
Violet BMQC and INS–1E (b) was stained with CellTracker
TM
Deep
Red. Partitioning analysis was performed in HTS and the fold change of the percentage of stained cells
was calculated compared to a PBS control. Error bars represent 1 s.d. of 4 technical replicates. Pairwise
t–test showed no significant changes of partitioning due to CellTracker
TM
staining (p> 0.05). Error bars
are within symbol size.
y = a× e(b×x0.5+c×x3) (1)
All binodal curves could be fitted with a Pearson’s r2 of at least 0.99. A change in shape
and location of the binodal in dependence of the polymer molecular weight was observed.
With increasing PEGmolecular weight, the binodal shifts towards lower PEG and dextran
concentrations. This trend was observed for both dextran molecular weights (Figure 3
g & h). The same effect was observed when increasing the dextran molecular weight. At
a given PEG molecular weight, the increase of the dextran molecular weight results in a
shift of the binodal towards lower PEG and dextran concentrations. In addition, changes
in binodal asymmetry could be observed in all phase diagrams. The higher the difference
in the molecular weight of PEG and dextran, the stronger the observed asymmetry. Tie–
line slopes increased slightly with increasing TLL, and the increase was very comparable
for different PEG and dextran molecular weights. We chose three screening points from
each phase diagram, with TLL of 7, 10 and 13 % (w/w), with the exception of the phase
diagrams of PEG 4,000. Due to the flatness of the binodals, even systems close to the
critical point had TLL of ≥ 12 % (w/w). Thus, we chose TLL of 12, 14 and 16% (w/w)
for PEG 4,000 – dextran 500,000 and 14 & 16% (w/w) for PEG 4,000 – dextran 70,000.
3.2 Influence of cell barcoding on their partitioning in PEG-
Dextran ATPS
Cell barcoding enables the evaluation of numerous cell lines in a single experiment. As
cell partitioning in ATPS is primarily dependent on cell surface properties, we chose
a barcoding reagent that does not bind to the cell surface, as for example described
by [25]. Instead, we chose the CellTrackerTM dyes, which are cell permeant fluorescent
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probes that are retained inside living cells after a glutathione S–transferase–mediated
reaction, with the exception of CellTrackerTM Deep Red, which is an amine–reactive
dye. Even though amine reactive dyes do not exclusively bind to proteins inside the cell,
CellTrackerTM Deep Red was used at very low concentrations (50 nM). Thus, we expected
that the CellTrackerTM dyes can be used for cell barcoding without significantly altering
their partitioning behavior. To confirm this assumption, we mixed CellTrackerTM Violet
BMQC stained and unstained HCT 116 cells and CellTrackerTM Deep Red stained and
unstained INS–1E cells, and studied their partitioning in a number of ATPS. We chose
ATPS composed of 4% PEG 8,000, 5% dextran 500,000, 0.11 M NaPi, pH 7.4, with a TLL
of 10.4 and of 4% PEG 8,000, 4% dextran 500,000, 0.11 M NaPi, pH 7.4, with a TLL of
6.9, which were previously shown to enable cell separation based on surface charge [10].
In addition, we chose a ATPS consisting of 4% PEG 8,000, 4% dextran 500,000, 0.01 M
NaPi, 0.138 M NaCl, pH 6.6, with a TLL of 6.9 which was previously shown to enable
cell separation based on their membrane lipid composition [10]. In Figure 4, the fold
change of the percentage of stained HCT 116 and INS–1E cells after partitioning is shown.
No significant enrichment or depletion of the CellTrackerTM stained cell populations was
observed (p>0.05).
3.3 Resolution of five model cell lines in charge-sensitive ATPS
in dependence of TLL and polymer molecular weight
The aim of this case study was to investigate the influence of TLL and polymer molecu-
lar weight on the resolution of different cell lines. To do so, the partitioning of five cell
lines that differ in species and tissue type was investigated in charge–sensitive ATPS at
different TLL and different combinations of PEG and dextran molecular weights. The
partitioning coefficient P of each cell line was defined as the ratio of cells in the top phase
(equation 2). The partitioning coefficient for the bottom phase was determined accord-
ingly.
P =
CountTP × V TP
CountC × V C
(2)
TP: top phase, C: PBS control, V: volume
In Figure 5 the partitioning coefficients of each cell line in dependence of TLL and poly-
mer molecular weight in charge–sensitive ATPS is summarized. The screenings revealed
a number of trends. Firstly, in the presence of NaPi, cells generally partitioned between
top phase and interface, which is well described for charge–dependent cell partitioning.
Further, partitioning coefficients decrease with increasing PEG molecular weight, while
an increase in dextran molecular weight results in an increase of cell recovery in the top
phase. Even though ATPS consisting of PEG 4,000 and either dextran 70,000 or 500,000
had considerably higher TLL very high partitioning coefficients were observed. Secondly,
when comparing the partitioning coefficients for a given molecular weight combination,
partitioning coefficients decrease with increasing TLL. This trend is more pronounced for
ATPS consisting of PEG 8,000 than PEG 4,000 and either dextran 70,000 or 500,000.
In ATPS consisting of PEG 20,000 and either dextran 70,000 or 500,000 less than 7%
























































































Figure 5: Partitioning coefficients of five model cell lines in ATPS containing 0.11 M NaPi, pH 7.4,
in dependence of PEG and dextran molecular weight and TLL. ATPS compositions are summarized in














































































Figure 6: Fold change of the percentage of five model cell lines compared to a PBS control in the top
phase of charge–sensitive ATPS in dependence of polymer molecular weight and TLL. ATPS compositions
are summarized in Table 1. Error bars represent 1 s.d. of 3 technical replicates. TLL: tie–line length.
of either cell line was recovered in the top phase, thus, cells were almost completely
adsorbed to the interface. In ATPS consisting of PEG 4,000 and dextran 70,000 approx-
imately 25% of the cells partitioned to the bottom phase, which is not consistent with
charge–dependent cell partitioning. These ATPS were thus not included in further anal-
yses. Thirdly, the same overall trends were observed when comparing the partitioning
coefficients of the five cell lines in a given ATPS. The cell line A549 has the strongest
affinity for the top phase, followed by HCT 116, L929, IEC–18, and INS–1E. However,
absolute partitioning coefficients as well as differences between partitioning coefficients
change in dependence of TLL and molecular weight of the polymers. This means that the
resolution, i.e. separability, between the cell lines changes. Next, we determined enrich-
ment/depletion factors for each cell line. In Figure 6 the fold change of the percentage
of each cell line in dependence of TLL and polymer molecular weight is summarized. The





We observed up to 3–fold enrichment of A549 cells in the top phase and > 30 fold de-
pletion of INS–1E cells from the top phase. Moreover, the resolution of the five cell lines
changes in dependence of TLL and polymer molecular weight. For example, in ATPS
consisting of PEG 4,000 dextran 70,000 large differences exist between the fold change–
values of IEC-18 and INS-1E, while those values are close to identical in ATPS consisting
of PEG 8,000 and dextran 70,000. This indicates that by changing the polymer molec-
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ular weight and TLL of charge–sensitive ATPS, the separation of two cell types might
be possible even if initial screenings indicate that they are not. In order to evaluate the
separability of the five cell lines in more detail, CCD–curves were calculated. CCD is a
well–established technique in liquid–liquid extraction, and has successfully been applied
in cell separation [10,13]. In CCD, the top phase is sequentially transferred, while the
bottom phase is retained. Between transfers, the ATPS are mixed and allowed to settle,
to achieve phase separation. Dependent on the application, the interface is either trans-
ferred or retained. Since cells partition between one of the bulk phases and the interface,
the interface is retained when cells partition between top phase and interface, and trans-
ferred when the cells partition between interface and bottom phase. As a consequence,
cells that partition mainly into the top phase move faster through the CCD–apparatus
than cells that partition mostly to the interface. As a result, the two cell types are sepa-
rated.





r(1 − P )n-r (4)
where F represents the fraction of the total cell population appearing in each theoretical
cavity (r) of the CCD–apparatus, and n the total number of transfers. We calculated
CCD–curves with 60 transfers for each cell line. The results are shown in Figure 7. The
distribution between the 60 theoretical cavities is strongly dependent on the partitioning
coefficients, and thus directly influences the resolution of the five cell lines [10,12]. In
ATPS in which high partitioning coefficients were obtained, e.g. ATPS # 3 and # 9 the
calculated CCD–curves are skewed towards the right, and only cell lines with the lowest
partitioning coefficients, i.e. IEC–18 and INS–1E can be separated from the mixture.
In ATPS # 9 A549 and HCT 116 have partitioning coefficients of 1 and thus do not
distribute in CCD. In ATPS in which very low partitioning coefficients were obtained,
e.g. ATPS # 7 and # 8 the calculated CCD–curves are skewed towards the left and very
little resolution can be obtained, whereas in ATPS in which intermediate partitioning
( 0.5) coefficients were obtained, e.g. ATPS # 1 and # 4 the calculated CCD–curves are
symmetrical and distribute evenly. Moreover, we observed that the resolution varies with
TLL and polymer molecular weight at comparable partitioning coefficients. In ATPS #
1 and # 4 for example, intermediate partitioning coefficients were obtained, however,
in ATPS # 4 A549 and HCT 116 cell can be separated but not in ATPS # 1. This
demonstrates that the combination of PEG and dextran molecular weights can influence
the separability of different cell types. Finally, the calculated CCD–curves indicate that
we identified conditions that enable peak separation of four of the five cell lines from the
mixture, indicating that very high purities and yields can be obtain with 60 transfers.
ATPS # 5 enables the isolation of A549 with > 99.9% purity and yield, and ATPS #
2 enables the separation of L929 cells with > 99.9% purity and > 45% yield. Moreover,
ATPS # 9 enables the isolation of IEC–18 with > 99.9% purity and > 95% yield and




















































































Figure 7: CCD–curves. CCD–curves were calculated for each cell line based on the partitioning coef-
ficients determined by HTS, with 60 theoretical transfers for ATPS # 1–11. The corresponding ATPS
composition and TLL are summarized in Table 1. TLL: tie–line length in % (w/w).
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4 Discussion
The aim of the present work was to investigate the influence of polymer molecular weight
and TLL on the resolution of five model cell lines in charge–sensitive ATPS. Prior to
the screenings, phase diagrams for all PEG and dextran molecular weight combinations
were determined. We chose charge–sensitive ATPS consisting of different combinations
of PEG 4,000, 8,000, and 20,000, and dextran 70,000 and 500,000, with three TLL per
combination. Trends in location and shape on the binodals are in good agreement with
literature [12]. Higher polymer molecular weights result in a shift of the binodal towards
lower concentrations of PEG and dextran, and the larger the difference in the molecular
weights of PEG and dextran, the more asymmetric is the binodal curve [12]. Further,
the influence of the barcoding strategy on the cell partitioning was evaluated prior to the
screenings. We expected that staining with CellTrackerTM dyes has no significant effect on
the partitioning behavior, since CellTrackerTM Green CMFDA und CellTrackerTM Violet
BMQC are cell permeant fluorescent probes that are retained inside living cells after a
glutathione S–transferase mediated reaction, thus, the cell surface remains unaltered. As
cell partitioning is largely dependent on cell surface properties, these dyes should not in-
fluence cell partitioning. CellTrackerTM Deep Red, however, is an amine reactive dye and,
thus, binds to cell surface proteins, which might influence cell partitioning by altering cell
surface properties. It was thus to evaluate, whether significant effects are observed at the
concentration used in this study. Partitioning studies showed no significant changes in
partitioning coefficients due to CellTrackerTM staining. Consequently, CellTrackerTM dyes
are an excellent tool for multiplexing in screenings investigating cell surface properties and
enable a substantial decrease in time and material consumption. Moreover, batch vari-
ability can be eliminated by analyzing numerous cell lines in the same experiment, and the
longevity (>72 h) and nontoxicity of the dyes enables prolonged screening times. Since
our data indicate that low concentrations of amine–reactive dyes do not significantly alter
cell partitioning in ATPS, it might be feasible to apply more complex barcoding strate-
gies, as for example described by Krutzik et al. [25], which enables a further increase
in throughput. Subsequently, we investigated the influence of polymer molecular weight
and TLL on the resolution of five model cell lines in charge–sensitive ATPS. In contrast
to smaller biomolecules, such as proteins and nucleic acids, cells partition between either
top or bottom phase and the interface, depending on the ATPS composition. In general,
partitioning in ATPS is driven by Brownian motion and interfacial forces. While the
Brownian motion distributes the molecule or particle randomly within the ATPS, the in-
terfacial tension acts to minimize the interfacial area. Accordingly, the interfacial tension
and consequently TLL and polymer molecular weight, play a major role cell partitioning
in ATPS [20]. The adsorption of cells and other particles to the interface reduces the inter-
facial area, and consequently the total free energy of the system. Thus, partitioning into
either phase can only take place if the interaction with the cell surface is strong enough
to ”pull” the cells out of the interface. The higher the interfacial tension, the stronger the
required interactions to enable partitioning to either bulk phase [10,12,20]. In addition,
salts with polyvalent anions, e.g. phosphate have a higher affinity for the dextran–rich
bottom phase that the PEG–rich top phase, while salts of halides, for example NaCl,
partition almost equally between the phases. Unequal partitioning of a salt leads to
the generation of an interfacial electrostatic potential difference (Donnan potential), and
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molecules and particles partition in such ATPS according to their charge [10,15,26,17].
In PEG–dextran ATPS containing phosphate with moderate interfacial tensions cells can
therefore be separated based on surface charge differences (charge–dependent partition-
ing). Cells have a negative net surface charge and consequently partition into the top
phase in ATPS containing phosphate [9,17]. These phenomena were observed throughout
the screening.
Both interfacial tension and Donnan potential increase with increasing TLL, but have
opposite effects on cell partitioning [18,20,27]. While the Donnan potential ”pulls” the
cells into the top phase, the interfacial tension promotes cell adsorption at the interface.
However, the increase of interfacial tension with TLL is stronger than the increase of the
potential difference between the phases. Thus, at some distance from the critical point,
the increase in interfacial tension offsets the increase in electrostatic potential difference
[10]. Forciniti and several others [12,20,27] described a logarithmic increase of the inter-
facial tension with increasing TLL, and an increase in interfacial tension with polymer
molecular weight at a given TLL, while a linear correlation between Donnan potential
and TLL has been described in several publications [18,28,29]. These finding correlate
well with the data presented in this work. With increasing TLL and polymer molecular
weight, cell adsorption to the interface increased. At a PEG molecular weight of 20,000
Da no partitioning into the top phase was observed, even at low TLL. This indicates
that the interfacial tension was too high for specific cell partitioning. Interestingly, the
change of dextran molecular weight from 500,000 to 70,000 Da, at a given PEG molecular
weight, did not result in an increase of partitioning coefficients, as assumed due to a de-
crease in interfacial tension, but a decrease. We assume that the partitioning coefficient
of phosphate is closer to 1 in these ATPS, resulting in lower Donnan potentials. This
assumption, however, will require further experimental validation. Our data showed that
combinations of low PEG molecular weights, i.e. ≤ 8,000 Da, and high dextran molecular
weights, i.e. 500,000 Da, at TLL between 10 and 15 % (w/w) enable high resolution of
the five model cell lines. This is in good agreement with the findings of Albertsson [12],
who describe an increase in partitioning coefficients when decreasing the PEG molecular
weight. We assume that a further decrease in PEG molecular or an increase in dextran
molecular weight might result in higher partitioning coefficients and in changes in res-
olutions. This however, needs to be validated in future work. Furthermore, our data
indicate that charge–dependent cell separation is the major driving force, independent
of TLL and polymer molecular weight, since the order of the affinity the five model cell
lines exhibited to the top phase is independent of TLL and polymer molecular weight.
However, the resolution between the five cell lines, which was evaluated by the calculation
of CCD–curves, changes with TLL and polymer molecular weight. Thus, comprehensive
screenings are necessary to investigate the separability of two cell populations. As hy-
pothesized by Walter et al. [10], factors other than surface charge may play a minor role
in charge–sensitive ATPS, and we assume that their contribution is dependent on TLL
and polymer molecular weight. In addition, the strength of the Donnan potential might
influence the resolution of cell lines in dependence of their net surface charge. This is
supported by the fact that A549 and HCT 116, which show the highest affinity for the
top phase, can be separated in ATPS with moderate mean partitioning coefficients, e.g.
ATPS # 3 but not in ATPS with high mean partitioning coefficients, e.g. ATPS # 4.
& 5. In addition, a number of other factors, such as phase densities and viscosities, and
3 PUBLICATIONS & MANUSCRIPTS
98
cell size and density may play a role [12]. However, the exact role and interaction of all
of these factors needs to be further investigated. In addition, the calculated CCD–curves
indicate that the differences in partitioning coefficients can be used for cell separation.
Our data show that we identified conditions that enable peak separation of each of the
five cell lines from the mixture in a single CCD–run, with the exception of HCT 116
where two consecutive CCD–runs are necessary. However, further experimental valida-
tion of the CCD–curves is required, since they are based on an ideal model. Likewise, it
should be noted that partitioning ratios of cells are highly dependent on vessel geometry,
fill volume, mixing efficiency, and phase separation time. Thus, these conditions need to
be identical in batch– and CCD– experiments, otherwise predicted CCD–curves will not
be accurate [10]. While the calculation of fold–change values are an excellent means to
evaluate separability of certain cell populations, CCD–models enable the estimation of
obtainable purities, yields and overall processing time, and are thus an excellent tool for
downstream process development of cell–based products. Finally, it should be noted that
Walter et al. showed that cell age, cell cycle stage, and the use of enzymes for cell disso-
ciation can influence cell partitioning [30–32]. Therefore, the effect of these parameters
on cell partitioning needs to be considered when designing a purification process.
5 Conclusion
We investigated the influence of TLL and polymer molecular weight on cell partitioning
in charge–sensitive ATPS. We showed that the interfacial tension, which is directly de-
pendent on TLL and polymer molecular weight, is a main factor in cell partitioning. The
present study showed that combinations of low PEG molecular weights and high dextran
molecular weights enable high resolution of different cell lines. Moreover, we showed that
the order of the affinity the five model cell lines exhibited to the top phase is independent
of TLL and polymer molecular weight, indicating that cell surface charge–dependent cell
partitioning due to an interfacial Donnan potential is the major driving force in ATPS
containing phosphate. However, the separability of the cell lines strongly depends on
TLL and polymer molecular weight. Thus, comprehensive screenings are necessary to
investigate the separability of specific cell populations. Finally, we demonstrated that
the combination of a HTS–platform for the investigation of cell partitioning in ATPS
with the here described barcoding strategy and the application of CCD–modelling, is a
powerful tool to study factors in cell separation and enables fast and directed downstream
process development for cell–based products.
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The availability of preparative–scale downstream processing strategies for cell–based
products presents a critical juncture between fundamental research and clinical devel-
opment. Aqueous two–phase systems (ATPS) present a gentle, scalable, label–free, and
cost–effective method for cell purification, and are thus a promising tool for downstream
processing of cell–based therapeutics. Here, we report the application of a previously de-
veloped robotic screening platform that enables high–throughput cell partitioning analy-
sis in ATPS. In the present case study we designed a purification strategy for two model
cell lines based on high–throughput screening (HTS)–data and countercurrent distribu-
tion (CCD)–modeling, and validated the CCD–model experimentally. The obtained data
show an excellent congruence between CCD–model and experimental data, indicating
that CCD–models in combination with HTS–data are a powerful tool in downstream
processing development. Finally, we showed that while cell cycle phase significantly in-
fluences cell partitioning, cell type specific differences in surface properties are the main
driving force in charge–dependent separation of HL–60 and L929 cells. In order to design
a highly robust purification process it is, however, advisable to maintain constant growth
conditions.
Keywords: high–throughput screening (HTS), label–free cell separation, aqueous two–
phase systems (ATPS), countercurrent distribution (CCD), cell cycle analysis
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1 Introduction
In the past decade, the development of cell–based therapeutics has moved from aca-
demic research to pharmaceutical industry, and has reached clinical trials. The need
for clinical–scale cell purification technologies thus has become more relevant than ever
[1–5]. Aqueous two–phase systems (ATPS) present a gentle, scalable, label–free, and
cost–effective method for cell purification, and are well established in downstream pro-
cessing of biopharmaceuticals, such as protein– and DNA–based drugs [6–8]. In contrast
to most state–of–the–art cell purification methods, ATPS–mediated cell separation does
not require cost–intensive clinical–grade antibodies, and the associated the regulatory
obstacles cease to apply [4, 5, 9, 10]. Polymer–polymer ATPS, particularly polyethylene
glycol (PEG)–dextran ATPS, have been extensively used to separate cells according to
their physical and chemical surface properties [7, 11]. Using multi–step processes such
as countercurrent distribution (CCD), even complex cell mixtures and closely related
cell types can be separated with high resolution and selectivity [7, 12, 13]. While the
mechanisms underlying cell partitioning in ATPS are not entirely understood, two main
factors in cell separation have been identified: surface charge and membrane lipid com-
position. Surface charge–dependent cell separation can be achieved in ATPS containing
phosphate (charge–sensitive ATPS), and partitioning coefficients of distinct cell types
could be correlated to their electrophoretic mobility. Charge–independent cell separation
is possible in ATPS containing sodium chloride (charge–insensitive ATPS), and parti-
tioning coefficients of distinct cell types have been correlated with their membrane lipid
composition [7, 11, 14, 15]. These phenomena are based on different partitioning prop-
erties of the respective salts. While sodium chloride partitions virtually equally between
the phases, phosphate has a stronger affinity to the dextran–rich bottom phase, result-
ing in an interfacial electrostatic potential difference (Donnan potential). This in turn
enables charge–independent and charge–dependent cell partitioning, respectively [7, 16,
17]. ATPS are thus a unique tool for cell separation and different cell types have been
separated with high selectivity and resolution, including cell types differing only in age
and cell cycle stage [7, 18, 19].
Nevertheless, the development of effective downstream processes for cell–based therapeu-
tics requires the optimization of various different parameters, hampering the widespread
application of ATPS in cell purification. In addition, it is unclear whether the high se-
lectivity, e.g. resolution of cell cycle phases, interferes with the feasibility of a robust
purification process. In former work, we developed an automated and miniaturized high–
throughput screening (HTS) platform for the analysis of cell partitioning in ATPS [13].
We showed that the combination of HTS and CCD–modeling enables fast, cost–effective,
and directed downstream process development for cell–based products. In the present
work, we used this HTS–platform to conduct a case study with the model cell lines HL–60
and L929. We designed a purification strategy based on HTS–data and CCD–modeling
and validated the CCD–model experimentally. Finally, we analyzed the influence of cell
cycle phase on cell partitioning and the resolution of HL–60 and L929, which may inter-
fere with the robustness of a purification process. As cells pass through the cell cycle a
multitude of changes takes places, such as changes in cell volume, density, DNA content,
protein expression, and consequently cell surface properties [19–22]. We thus evaluated
to which extent cell cycle stage, and thus growth phase, influences a purification process.
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2 Materials & Methods
2.1 Disposables
1.3 mL deep well plates (Nalgene Nunc, Rochester, NY, USA, cat. 260252) and 96–well
U–bottom plates (BD FalconTM , Franklin Lakes, NJ, USA, cat. 353910) were used for
ATPS preparation and flow cytometry, respectively. For any other purpose, polypropylene
flat–bottom microplates (Greiner Bio–One, Kremsmuenster, Austria, cat. 655261) were
used.
2.2 Software and data processing
The Tecan Freedom Evo 200 was controlled by Evoware 2.5 SP2 standard (Tecan, Crail-
sheim, Germany). For advanced applications, i.e. sampling and cell resuspension, visual
basic scripts were fed into Evoware. Data evaluation and visualization was performed
with Excel 2013 (Microsoft, Redmond, WA, USA) and Matlab R2014a (The MathWorks,
Natick, ME, USA). Statistical data analysis was performed in Matlab R2014a. BD FACS-
Diva 8.0 (BD Biosciences, San Jose, CA, USA) was used for raw data analysis, to control
the BD LSR Fortessa Cell Analyzer, and to calculate compensation of spectral overlap.
Visualization of flow cytometry data was performed in Flow Jo V10 (Tree Star, Ashland,
OR, USA).
2.3 Preparation of buffers and stock solutions
All buffers and polymer solutions were prepared as previously described [13].
2.4 Cell culture
All cell culture reagents were purchased from Life TechnologiesTM . HL–60 and L929 cells
were cultured as previously described [13]. The suspension cell line HL–60 was split to a
concentration of 2 x 105 cells per mL every 3–4 days to a maximum passage number of
100. L929 cells were split every 3–4 days to a concentration of 2 x 104 cells per cm2 for
a maximum of 20 passages.
2.5 Cell TrackerTM, antibody and viability staining
For partitioning analysis of HL–60 and L929 cells, HL–60 cells were stained with Cell-
TrackerTMOrange CMRA (Life TechnologiesTM) as previously described [13]. For viability
staining, cells were stained with 7–AAD (Biolegend, San Diego, CA, USA) according to
the manufacturer’s instructions.
2.6 Cell quantification using high–throughput flow cytometry
Cells were quantified using high–throughput flow cytometry as described in previous work
[13, 23].
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2.7 Automated high–throughput screening of cell partitioning in
aqueous two–phase systems
The automated HTS–method was used as described in previous work [13]. The screening
was performed on a Tecan Freedom Evo R© 200 liquid–handling station (LHS). Next, the
sample plates were transferred to the high–throughput sampler of the BD LSR Fortessa
for cell quantification and analysis. ATPS were prepared in a 1.3 mL 96–well plate
(final volume: 637 µL). After mixing and addition of cells (5 x 105 cells per well), phase
separation was achieved by settling (30 minutes, RT) and sampling was performed as
previously described [13]. During the sampling procedure samples were 5–fold diluted in
staining buffer. Staining was subsequently performed by adding an equal volume of 2 x
staining buffer containing 7–AAD. After incubation for 10 minutes at RT in the dark,
flow cytometric analysis was performed.
2.8 Multi–stage partitioning
Multi–stage partitioning was performed manually in 1.5 mL Eppendorf tubes with a
total volume of 637 µL (equal volumes of top and bottom phase). Cells were prepared as
described above and added in a volume of 13 µL at a concentration of 3.8 x 107 cells per
mL. The ATPS were mixed by inverting the tubes five times, and the phases were allowed
to separate by gravity (40 min, RT). Subsequently, the top phase was carefully removed
and transferred to an equal volume of bottom phase. 30 µL sample were taken and sample
dilution and flow cytometric analysis was performed identically to the HTS–screening.
2.9 Cell cycle analysis
Cell cycle analysis was performed by DNA–content analysis with 4’, 6–diamidino–2–
phenylindole (DAPI). The experiment layout was the same as described above to ensure
comparability between the experiments. 3 x 106 cells per well in 13 µL PBS were added to
each well. After mixing and phase separation, 100 µL were manually sampled from each
well. The controls were resuspended before sampling. 2 x 8 control and ATPS samples
were pooled to obtain sufficient cell numbers for cell cycle analysis. The pooled samples
were washed twice with 15 mL PBS + 10% FBS and fixed with ice–cold 70% ethanol at
4◦C overnight. Next, cells were washed twice and resuspended in 500 µL staining buffer
+ 1 µg/mL DAPI (Life TechnologiesTM). After incubation for 30 minutes at 37◦C, the
samples were analyzed by flow cytometry. Measurement was performed at a maximum
acquisition rate of 400 events per second, and 150.000 events were recorded per sample.
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2.10 Statistical data analyis
Pre–processing of screening data was performed as described in a previous publication
[13]. Mean comparison was performed by applying a two–sided student’s t–test, pro-
vided that equal variances were asserted by an F–test. Error propagation was considered
throughout our analyses [24]. DNA–content based cell cycle analysis was performed in
FlowJo, using the Watson pragmatic model. Flow cytometry data were pre–processed to
eliminate debris and aggregates. Discrimination between the two cell types was performed
based on CellTrackerTM Orange CMRA staining and DNA–content was determined by
the DAPI signal.
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3 Results
3.1 Resolution of the two model cell lines HL-60 and L929 in
dependence of salt composition, pH, and TLL
The aim of the first part of this case study was to optimize separation conditions for two
model cell lines based on HTS–data. We chose the promyelocytic cell line HL–60 and the
murine fibroblast cell line L929, since we expected these cell lines to differ significantly
in their surface properties due to their different origins. In a series of screenings, we
investigate the influence of tie–line length (TLL), salt composition, and pH on the reso-
lution of the two cell lines. To enable multiplexing, we stained the HL–60 cells with Cell
TrackerTMOrange CMRA. An overview of the staining and data deconvolution strategy
is illustrated in Figure 1. In analogy to previous studies [13], we investigated the reso-
lution of HL–60 and L929 cells in dependence of the ratio of sodium phosphate (NaPi)
and sodium chloride (NaCl), pH, and TLL, representing conditions where both charge–



























Figure 1: Multiplexing in HT–partitioning analysis in ATPS. HL–60 cells are stained with
CellTracker
TM
Orange CMRA and pooled with unstained L929 cells before HT–partitioning analysis in
ATPS. Cell quantification and analysis is performed by HT–flow cytometry. After data deconvolution,
the partitioning coefficients of the two cell lines can be determined. The live cell population of each cell
line was gated based on 7–AAD staining. FSC–A: Forward scatter peak area, SSC–A: side scatter peak
area, FSC–H: Forward scatter peak height. HT: high–throughput.
The partitioning coefficient P of each cell line was defined as the fraction of cells in the
top phase (equation 1). The partitioning coefficient for the bottom phase was determined
accordingly.
P =
CountTP × V TP
CountC × V C
(1)
TP: top phase; C: PBS control; V: volume
In Figure 2A & B the partitioning coefficients of each cell line in dependence of salt
composition, pH, and TLL are summarized. ATPS compositions are summarized in Ta-
ble 1. In addition, we determined enrichment/ depletion factors for the two cell lines.
In Figure 2C & D the fold change of the percentage of each cell line in dependence
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Figure 2: HT–partitioning analysis of the cell lines HL–60 and L929 in PEG–dextran ATPS, in depen-
dence of salt composition, pH, and TLL. (A–B) Partitioning coefficients (P) of HL–60 and L929. Cell
partitioning was analyzed in PEG 8,000–dextran 500,000 ATPS with varying ratios of NaPi and NaCl.
While the overall salt concentration was kept constant and isotonic, the molar ratio of NaPi and NaCl
were varied (90%, 70%, 50%, 30%, 10% and 0% mM NaCl) at an intermediate TLL of 10.7% (w/w) at
pH 6.6, 7.0 and 7.4 (A), and at three different TLL at pH 6.6 (B). The heat maps represent the mean
partitioning coefficients (P) of live cells in each phase (n=2 technical replicates). (C–D) Fold change of
the percentage of HL–60 and L929 compared to a PBS control at an intermediate TLL of 10.7 at pH
6.6, 7.0 and 7.4 (C), and at three different TLL (7.3, 10.7, and 19.3 % (w/w)) at pH 6.6 (D). Error bars
represent s.d. (n= 2 technical replicates). TLL: tie–line length, HT: high–throughput.






As expected, we observed considerable differences in partitioning coefficients of HL–60
and L929. At an intermediate TLL of 10.7% (w/w), both cell lines partitioned increas-
ingly to the top phase with increasing phosphate concentration. We found that HL–60
has significantly higher partitioning coefficients than L929 at high phosphate concentra-
tions, i.e. in charge–sensitive ATPS. We further observed a slight pH–dependence, with
an increase of partitioning coefficients with increasing pH (Figure 2A). The fold enrich-
ment of HL–60 in the top phase, on the other hand, decreases with increasing pH (Figure
2C). Moreover, we observed excellent resolution of HL–60 and L929 in charge–sensitive
ATPS at intermediate TLL (Figure 2B & D, middle panel), but not close to the








TLL: 10.7 TLL: 7.3 TLL: 19.3
Figure 3: Selection of separation conditions for HL–60 and L929. The partitioning ratio of HL–60
(KHL–60) was plotted against the quotient of the partitioning ratios of HL–60 and L929 (Q) obtained from
the data shown in Figure 2. The red box indicates the conditions selected for multi–stage partitioning
experiments. Error bars represent s.d. (n= 2 technical replicates).
At short TLL (7.3% (w/w)) and low phosphate concentrations, i.e. charge–insensitive
ATPS, we observed a significant enrichment of L929 cells in the top phase (Figure 2B &
D, left panel). Further, we observed no partitioning into the top phase at long tie–lines
(13.3% (w/w)) (Figure 2B, right panel). At high phosphate concentrations, both cell
lines accumulated at the interface. With decreasing phosphate concentration, however,
we observed increasing partitioning into the bottom phase and an enrichment of L929
cells (Figure 2B & D, right panel). To select ATPS that enable maximal resolution,
partitioning ratios (K), and the quotient of the partitioning ratios of HL–60 and L929










where P represents the fraction of cells in the top phase and I the fraction of cells at
the interface. We investigated Q in dependence of K to select ATPS that give maximal
resolution of the two cell lines (Figure 3). We obtained partitioning ratios over three
orders of magnitude and Q–values between 0.2 and 6.9. As previously shown [13], ATPS
that yield K–values around 1 and Q–values << 1 >> enable maximal resolution in CCD.
All ATPS that fulfill these criteria were ATPS with high phosphate concentrations and
intermediate TLL (10.7% (w/w)). For further studies we chose an ATPS consisting of
4% PEG 8,000, 5% dextran 500,000, 0.11M NaPi, at pH 7.4, with K–values of 0.5 ± 0.1
(mean ± s.d.) and 1.8 ± 0.1 for L929 and HL–60, respectively, and a Q–value of 4.0 ±
1.2. Based on earlier studies we prioritized K–values over Q–values, since this enabled
maximal resolution in a CCD–model [13].
Table 1. Summary of ATPS-compositions.








[#] [% (w/w)] [% (w/w)] [mM] [mM] [–] [% mM]
1 4 4 110 0 6.6 0
2 4 4 100 10 6.6 10
3 4 4 80 40 6.6 30
4 4 4 60 60 6.6 50
5 4 4 40 90 6.6 70
6 4 4 10 120 6.6 90
7 4 5 110 0 6.6 0
8 4 5 100 10 6.6 10
9 4 5 80 40 6.6 30
10 4 5 60 60 6.6 50
11 4 5 40 90 6.6 70
12 4 5 10 120 6.6 90
13 4 5 110 0 7.0 0
14 4 5 100 10 7.0 10
15 4 5 80 40 7.0 30
16 4 5 60 60 7.0 50
17 4 5 40 90 7.0 70
18 4 5 10 120 7.0 90
19 4 5 110 0 7.4 0
20 4 5 100 10 7.4 10
21 4 5 80 40 7.4 30
22 4 5 60 60 7.4 50
23 4 5 40 90 7.4 70
24 4 5 10 120 7.4 90
25 5 7 110 0 6.6 0
26 5 7 100 10 6.6 10
27 5 7 80 40 6.6 30
28 5 7 60 60 6.6 50
29 5 7 40 90 6.6 70
30 5 7 10 120 6.6 90
3.2 Validation of CCD–model
The aim of the second part of this case study was to validate a CCD–model based on
batch–data. To facilitate manual handling, these experiments were performed in 1.5 mL
Eppendorf tubes instead of 96–well plates. Since cell partitioning in ATPS is highly de-
pendent on fill volume, vessel geometry, and mixing intensity, batch experiments were
performed to optimize phase separation time and obtain accurate partitioning coefficients
(Figure 4A).





















































































Figure 4: Validation of the CCD–model. (A) Selection of a suitable phase separation time for manual
multi-stage partitioning experiments. Cell partitioning was analyzed in an ATPS consisting of 4% PEG
8,000, 5% dextran 500,000, 0.11 M NaPi, pH 7.4, as indicated in Figure 3. The partitioning coefficient
for the entire cell population is shown on the primary ordinate and the fold change of HL–60 cells in
the top phase is depicted on the secondary ordinate. The arrow represents the selected phase separation
time. Error bars represent s.d. (n= 2 technical replicates). (B) CCD–model with 12 (left panel) and 24
(right panel) theoretical transfers for the conditions indicated in (A). (C–D) Experimental validation of
the CCD–model shown in (B). (C) Flow cytometric analysis of the ratio of HL–60 and L929 cells over 6
partitioning steps. The two cell lines were distinguished based on CellTracker
TM
Orange CMRA staining.
Lighter colors were selected for increasing numbers of partitioning steps. (D) Comparison of theoretical
and experimental CCD–data. Error bars represent s.d. (n= 2 technical replicates).
As expected, we observed discrepancies in partitioning coefficients and fold change of
the percentage of HL–60 cells in the top phase. In addition, the required phase separation
time was significantly longer, with 60 instead of 30 minutes to obtain maximal resolution.
For the experimental validation of the CCD–model, we chose a phase separation time of
40 minutes, which is the shortest phase separation time that enables resolution of the
two cell lines. We determined partitioning coefficients of 1.00 ± 0.12 (mean ± s.d.) and





r(1 − P )n-r (5)
where F represents the fraction of the total cell population appearing in each theoretical
cavity (r) of the CCD–apparatus, and n represents the total number of transfers. CCD–
curves with 12 and 24 transfers are shown in Figure 4B. At a target purity of 99.9%,
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86.5% and 99.0% yield can be achieved with 12 and 24 transfers, respectively. Due to
the long phase separation times, only 5 consecutive transfers were performed manually.
Flow cytometry data and the comparison of modeling and experimental data are shown
in Figure 4C & D. Since the partitioning coefficient of HL–60 cells is 1.0, L929 cells
are ”washed–out” in each step, while the number of HL–60 cells remains almost constant
(Figure 4C). In addition, the experimental data show excellent congruence with the
CCD–model (Figure 4D). It should be noted that each purification step was modeled
based on the results of the previous purification step, to avoid bias due to imprecise phase
transfer.
3.3 Influence of cell cycle phase on partitioning in charge-sensitive
ATPS
Aim of the third part of this case study was to investigate how cell cycle phase, and
thus cell growth, influences cell partitioning in charge–sensitive ATPS. For this part of
the study we selected conditions that enable maximal differences in partitioning coeffi-
cients and thus prioritized Q–values over K–values. The selected ATPS consisted of 4%
PEG 8,000, 5% dextran 500,000, 0.11 M NaPi, at pH 6.6. Literature indicates that cell
partitioning in charge–sensitive ATPS is dependent on cell cycle stage [19, 21], however,
more comprehensive studies have not been conducted so far. We thus aimed to analyze
to which degree cell partitioning is based on cell type specific properties, and to which
degree on the cells cycle phase. This was done by analyzing cell cycle distribution of
HL–60 and L929 cells after partitioning in ATPS, compared to PBS controls (Figure
5). As in previous screenings, discrimination between the two cell lines was performed
based on CellTrackerTMOrange CMRA staining and we observed a fold change of the
percentage of HL–60 and L929 cells in the top phase of 1.7 ± 0.03 and 0.3 ± 0.01 (mean
± s.d.), respectively (Figure 5A). Subsequently, DNA–content based cell cycle analysis
was performed for each cell line individually, and cell cycle distribution after partitioning
in ATPS was compared to PBS controls (Figure 5B–D). We observed a significant de-
pletion (p<0.05) of S–phase cells from the top phase for both cell lines. The fold change
of S–phase cells was 0.8 ± 0.04 and 0.7 ± 0.08 (mean ± s.d.) for HL–60 and L929,
respectively (Figure 5D). While the overall trends were comparable for both cell lines,
a significant enrichment (p<0.05) of G2/M–phase cells was only observed for HL–60 cells
with a fold change of 1.3 ± 0.06 (mean ± s.d.), while no significant enrichment was
observed for L929 cells.
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Figure 5: Influence of cell cycle stage on the partitioning in charge–sensitive ATPS. (A) The model cell
lines HL–60 and L929 were stained with CellTracker
TM
Orange CMRA ,and partitioning was analyzed in
a charge–sensitive ATPS at a TLL of 10.7 (4% PEG 8,000, 5% dextran 500,000, 0.11 M NaPi, pH 6.6).
(B–C) After data deconvolution, DNA-content dependent cell cycle distribution of both cell lines was
analyzed based on the DAPI–signal using the Watson pragmatic model. Mean ± s.d. of the percentage of
cells in each cell cycle phase (n=2 technical replicates) are indicated. (D) Fold change of the percentage
of cells in each cell cycle phase compared to a PBS control. Asterisks indicate significant changes (p<
0.05) as determined by a Student’s t-test. Error bars represent s.d. (n= 2 technical replicates).
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4 Discussion
The aim of this case study was to optimize separation conditions for the two model cell
lines HL–60 and L929 based on HTS–data and CCD–modelling. Further, we aimed to
validate the CCD–model experimentally and investigate the influence of cell cycle phase
on cell partitioning.
In the first part of this study we performed a series of screenings to investigate the
influence of TLL, salt composition, and pH on the resolution of the two cell lines (Figure
2). As expected, we observed the same overall trends described before [7, 13]. In addition,
HL–60 cells showed significantly higher partitioning coefficients than L929 cells in charge–
sensitive ATPS, indicating a higher net surface charge [7]. Since the electrostatic potential
difference increases with increasing TLL [26–28], we observed excellent resolution of HL–
60 and L929 in charge–sensitive ATPS, at intermediate TLL but not close to the critical
point. In charge–insensitive ATPS, a significant enrichment of L929 cells was observed
in the top phase, indicating differences in the membrane lipid composition of the two cell
lines [7, 29]. Even though the electrostatic potential difference increases with increasing
TLL [26–28 ], we observed no partitioning into the top phase at long tie–lines. This is due
to the fact that at some distance from the critical point, the increase in interfacial tension
offsets the increase in electrostatic potential difference [7]. Interestingly, we observed cell
partitioning into the bottom phase and an enrichment of L929 cells at intermediate and
long tie–lines at low phosphate concentrations. This has not been associated with specific
cell surface characteristics so far. However, we observed an enrichment of HL–60 cells
in all of the ATPS, indicating that charge–associated properties rather than membrane
lipid associated properties are implied. Based on these HTS–data we selected ATPS that
enable optimal separation using CCD (Figure 3) [13].
In the second part of this study we validated the CCD-model experimentally (Figure
4). This has been performed for small molecules and proteins but not for mammalian
cells, however, it has been assumed that CCD–models are highly accurate if all relevant
parameters are kept constant and the cell types to be separated are homogenous [7, 12,
30]. As previously described, cell partitioning and phase separation times are highly
dependent on vessel geometry, fill volume, and mixing intensity [7, 11], thus, we observed
significant differences in partitioning coefficients and phase separation times when using
1.5 mL Eppendorf tubes instead of 96–well plates. Experimental validation of the CCD–
model showed excellent congruence between the model and experimental data. This
indicates that predicted CCD–curves are highly accurate if all relevant parameters are
kept constant and phase transfer is accurate. The strength of this HTS–platform is its
versatility and applicability for most labware types, which enable direct optimization
of all relevant parameters in high–throughput. Depending on target yield and purity,
and maximal processing time, separation conditions can be further optimized and final
purification conditions can be chosen. In future studies, the use of design of experiments
(DoE) will enable the simultaneous optimization of numerous parameters, and the fast
and cost–effective design of a purification process for various applications.
In the third part of this study we investigated the influence of cell cycle phase on a
purification process. Our data show a significant decrease in partitioning coefficients of
S–phase cells and an enrichment of cells in in G1– & G2/M–phase (Figure 5). The
change of cell surface properties with cell growth and cell cycle phase has been described
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in several publications [19–22]. Pinaev and Brent & Foster described an increase in
electrophoretic mobility of mitotic / metaphase HeLa cells, as well as an increase of their
partitioning coefficients in charge–sensitive ATPS, indicating an increase in cell surface
charge. We observed this trend for HL-60 cells, but not for L929 cells. This may, however,
be due to the low percentage of G2/M–phase cells of L929, which makes small changes
in the percentage of G2/M–phase cells more difficult to detect. In addition, Walter et
al. described an increase in partitioning coefficients of K–562 cells in late S–phase and
G2/M–phase compared to cells in G0/G1 and early M–phase. These findings are thus
in excellent agreement with the data shown here. Moreover, our data show that while
cell cycle phase significantly influences cell partitioning, cell type specific differences in
surface properties have a much greater influence on cell partitioning. This is supported by
the fact that the two cell lines showed almost ideal behavior in multi–stage partitioning.
If the heterogeneity due to differences in cell cycle distribution had a major influence
on cell partitioning we would have observed major discrepancies between theoretical and
experimental CCD–data. It can, however, not be excluded that we may observe slight
discrepancies at a higher number of transfers, due to differences in the partitioning based
on cell cycle phase. To conclude, even though cell cycle phase significantly influences
cell partitioning, cell type specific differences in surface properties have a much greater
influence on partitioning. Nonetheless, growth phase should be kept constant in order to
obtain a highly robust purification process.
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4 Conclusion & Outlook
This thesis provides insights into novel tools for downstream processing of cell-based
therapeutics. A main focus of this thesis was the development of preparative-scale down-
stream processing strategies using ATPS. The challenge of laborious empirical process
optimizations and the lack of mechanistic understanding in ATPS research was addressed
by the development of an integrated HTS-platform that enables HT-cell partitioning anal-
ysis in ATPS.
In this context, the following issues were addressed:
• Development of analytical technologies for HTS
• Design of an automated robotic screening platform
• Systematic investigation of key parameters in cell partitioning
• Development of downstream processing strategies based on HTS-data and experi-
mental validation
In the first part of this work a comparative study on HT-cell quantification assays was
performed, where sensitivity, dynamic range, and precision were evaluated for a number
of state-of-the-art cell quantification methods that differ in their respective mechanism.
This benchmark study was designed as a guide for selecting HT-cell quantification assays
for a specific application. In addition, it identified HT-flow cytometry as an ideal tool for
cell quantification and multi-parametric analysis in HT-DSP development for cell-based
products.
In the second part of this thesis an automated robotic screening that enables HT-cell
partitioning analysis in ATPS was developed and validated. The study demonstrated
that this setup enables fast and systematic investigation of factors influencing cell par-
titioning. In combination with DoE approaches and CCD-modeling it thus presents a
powerful enabling technology for translational research.
In the course of this thesis several case studies on HT-DSP development for cell-based
products were conducted with numerous model cell lines. The development of a barcoding
strategy enabled the multiplexing of numerous cell lines in HTS, which facilitated a sig-
nificant reduction in time and material consumption. The case studies further identified
numerous key parameters in ATPS-mediated cell separation, and provide a benchmark
for future applications. The performed case studies demonstrated that the separability
of numerous cell lines from a complex mixture, as well as, two distinct cell populations
from a differentiation mix is feasible with excellent purity and yield in a CCD-setup. Ex-
perimental validation of the CCD-model demonstrated excellent accuracy of the model.
The studies further revealed that cell type specific differences are the major driving forces
in cell partitioning rather than cell cycle distribution, and that robust and reproducible
purification processes are thus feasible.
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4 CONCLUSION & OUTLOOK
Future exploitation of this platform will enable more directed DSP development and
facilitate a better understanding of the mechanisms underlying cell partitioning in ATPS.
Due to the versatility of Tecan LHS, the screening platform can easily be adapted to count-
less applications. Up- and downscaling can be performed by simply changing the labware
type, and the influence of settling time, mixing intensity, fill volume, and vessel geometry
can be studied. This enables the simultaneous optimization of numerous parameters for
purification processes using a CCD-device. Likewise, various analytical methods, such
as different PCR-techniques, ELISA, and high-content screenings (HCS) can be directly
integrated into the screening process. The use of HTS-data in combination with DoE
strategies and CCD-models will enable the simultaneous investigation of numerous pa-
rameters and the optimization of separation conditions for various applications.
The combination of HTS-data with numerous cellular parameters, e.g. surface parame-
ters, such as zeta-potential, or complex spectral data, such as Raman-spectra, and the
application of statistical tools, such as multivariate data analysis (MVDA), will provide
a more detailed mechanistic understanding and will eventually enable a shift towards a
more model-based DSP design.
In conclusion, the here developed technology has facilitated faster, cheaper, and more
directed DSP development for cell-based therapeutics, and has demonstrated that ATPS
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ALL Acute lymphoblastic leukemia
ALS Amyotrophic lateral sclerosis
ASC Adult stem cells
ATMP Advanced therapy medicinal product
ATP Adenosine triphosphate
ATPS Aqueous two-phase systems
BSA Bovine serum albumin
CAR Chimeric antigen receptor
CCC Countercurrent chromatography
CCD Countercurrent distribution
CNS Central nervous system
CPC Centrifugal partition chromatography







DoE Design of experiments




ELISA Enzyme-linked immuno sorbent assay
ESC Embryonic stem cells
FACS Fluorescence activated cell sorting
FDA U.S. food and drug administration
FFF Field flow fractionation
GvHD Graft-vs-host disease
HBSS Hank’s balanced salt solution
HCS High-content screening
hESC Human embryonic stem cells
hiPSC Human induced pluripotent stem cells
HLA Human leukocyte antigen
HSC Hematopoietic stem cells
HT High-throughput
HTPD High-throughput process development
HTS High-throughput screening
iPSC Induced pluripotent stem cells
kDa kilo dalton
mAb Monoclonal antibody
MACS Magnetic activated cell sorting
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MSC Mesenchymal stem cells




NK Natural killer cells
NSC Neural stem cells
PBMC Peripheral blood mononuclear cells
PCR Polymerase chain reaction
PEG Polyethylene glycol
pH Pondus hydrogenii
PSC Pluripotent stem cells
QL Quantitation limit
STL Slope of tie-line
TLL Tie-line length
Tregs Regulatory T-cells
UV Ultraviolet
wi Weighting factor
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